MCID: ACN019
MIFTS: 31

Acanthamoeba Keratitis

Categories: Eye diseases, Rare diseases

Aliases & Classifications for Acanthamoeba Keratitis

MalaCards integrated aliases for Acanthamoeba Keratitis:

Name: Acanthamoeba Keratitis 52 17 71

Classifications:

MalaCards categories:
Global: Rare diseases
Anatomical: Eye diseases


External Ids:

UMLS 71 C0000880

Summaries for Acanthamoeba Keratitis

MalaCards based summary : Acanthamoeba Keratitis is related to vasculitis and retinal artery occlusion. An important gene associated with Acanthamoeba Keratitis is APOH (Apolipoprotein H), and among its related pathways/superpathways is Complement and coagulation cascades. The drugs Polihexanide and Dibrompropamidine have been mentioned in the context of this disorder. Affiliated tissues include eye, testes and skin.

Wikipedia : 74 Acanthamoeba keratitis is a rare disease in which amoebae invade the cornea of the eye, and affects... more...

Related Diseases for Acanthamoeba Keratitis

Diseases related to Acanthamoeba Keratitis via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 123, show less)
# Related Disease Score Top Affiliating Genes
1 vasculitis 29.6 MBL2 APOH
2 retinal artery occlusion 29.6 F5 APOH
3 granulomatous amebic encephalitis 11.5
4 keratitis, hereditary 11.4
5 herpes simplex 10.7
6 fungal keratitis 10.7
7 corneal ulcer 10.6
8 corneal disease 10.6
9 scleritis 10.6
10 uveitis 10.5
11 cataract 10.5
12 iridocyclitis 10.5
13 stromal keratitis 10.5
14 hypopyon 10.4
15 corneal edema 10.4
16 mature cataract 10.4
17 corneal neovascularization 10.4
18 neuritis 10.4
19 eye disease 10.4
20 amoebic keratitis 10.4
21 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.4
22 yemenite deaf-blind hypopigmentation syndrome 10.4
23 corneal abscess 10.4
24 myopia 10.4
25 herpes simplex virus keratitis 10.3
26 endophthalmitis 10.3
27 conjunctivitis 10.3
28 dacryoadenitis 10.3
29 keratoconus 10.3
30 superficial keratitis 10.3
31 keratopathy 10.3
32 keratoconjunctivitis 10.3
33 infective keratitis 10.3
34 dry eye syndrome 10.2
35 punctate epithelial keratoconjunctivitis 10.2
36 cholera 10.2
37 chorioretinitis 10.2
38 autoimmune disease 10.0
39 neutrophil migration 10.0
40 uncombable hair syndrome 1 10.0
41 immune deficiency disease 10.0
42 proteasome-associated autoinflammatory syndrome 1 10.0
43 3-methylglutaconic aciduria, type iii 10.0
44 astigmatism 10.0
45 intraocular pressure quantitative trait locus 10.0
46 pulmonary hypertension 10.0
47 ptosis 10.0
48 neuroretinitis 10.0
49 suppression amblyopia 10.0
50 amblyopia 10.0
51 allergic conjunctivitis 10.0
52 trachoma 10.0
53 retinal vasculitis 10.0
54 scleral staphyloma 10.0
55 sympathetic ophthalmia 10.0
56 retinal ischemia 10.0
57 shipyard eye 10.0
58 branch retinal artery occlusion 10.0
59 central retinal artery occlusion 10.0
60 anterior scleritis 10.0
61 irregular astigmatism 10.0
62 iritis 10.0
63 sclerosing keratitis 10.0
64 optic nerve disease 10.0
65 plague 10.0
66 retinitis 10.0
67 chronic fatigue syndrome 10.0
68 chickenpox 10.0
69 ocular hypertension 10.0
70 refractive error 10.0
71 central corneal ulcer 10.0
72 47,xyy 10.0
73 cytokine deficiency 10.0
74 endotheliitis 10.0
75 rapidly involuting congenital hemangioma 10.0
76 argyria 10.0
77 pyelonephritis 9.8 MBL2 CXCL2
78 may-thurner syndrome 9.8 F5 APOH
79 spinal cord infarction 9.8 F5 APOH
80 sudden sensorineural hearing loss 9.8 F5 APOH
81 catastrophic antiphospholipid syndrome 9.8 F5 APOH
82 antiphospholipid syndrome 9.8 F5 APOH
83 prothrombin deficiency, congenital 9.8 F5 APOH
84 cerebral sinovenous thrombosis 9.8 F5 APOH
85 thrombosis 9.8 F5 APOH
86 pregnancy loss, recurrent 1 9.8 F5 APOH
87 meningococcemia 9.8 MBL2 F5
88 sneddon syndrome 9.8 F5 APOH
89 intracranial thrombosis 9.8 F5 APOH
90 peripheral vertigo 9.8 F5 APOH
91 thrombophilia due to activated protein c resistance 9.8 F5 APOH
92 thrombophilia 9.8 F5 APOH
93 factor xii deficiency 9.8 F5 APOH
94 carotid artery occlusion 9.8 F5 APOH
95 ischemic colitis 9.8 F5 APOH
96 purpura fulminans 9.8 F5 APOH
97 antithrombin iii deficiency 9.8 F5 APOH
98 thrombophlebitis 9.8 F5 APOH
99 retinal vascular occlusion 9.8 F5 APOH
100 legg-calve-perthes disease 9.8 F5 APOH
101 central retinal vein occlusion 9.7 F5 APOH
102 retinal vein occlusion 9.7 F5 APOH
103 pulmonary artery disease 9.7 F5 APOH
104 protein s deficiency 9.7 F5 APOH
105 portal vein thrombosis 9.7 F5 APOH
106 protein c deficiency 9.7 F5 APOH
107 thrombophilia due to thrombin defect 9.7 F5 APOH
108 placental abruption 9.7 F5 APOH
109 intracranial hypertension 9.7 F5 APOH
110 rheumatic disease 9.7 MBL2 APOH
111 budd-chiari syndrome 9.7 F5 APOH
112 severe pre-eclampsia 9.7 F5 APOH
113 blood coagulation disease 9.7 F5 APOH
114 homocysteinemia 9.7 F5 APOH
115 placenta disease 9.6 F5 APOH
116 pulmonary embolism 9.6 F5 APOH
117 cerebral palsy 9.6 MBL2 F5
118 patent foramen ovale 9.6 F5 APOH
119 bacterial infectious disease 9.5 MBL2 CXCL2
120 hellp syndrome 9.4 MBL2 F5 APOH
121 behcet syndrome 9.4 MBL2 F5 APOH
122 rheumatoid arthritis 9.3 MBL2 CXCL2 APOH
123 cerebrovascular disease 9.2 F5 APOH

Graphical network of the top 20 diseases related to Acanthamoeba Keratitis:



Diseases related to Acanthamoeba Keratitis

Symptoms & Phenotypes for Acanthamoeba Keratitis

Drugs & Therapeutics for Acanthamoeba Keratitis

Drugs for Acanthamoeba Keratitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 51, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Polihexanide Approved, Investigational Phase 3 28757-47-3
2 Dibrompropamidine Experimental Phase 3 496-00-4
3
Propamidine Experimental, Investigational Phase 3 104-32-5
4 Hypoglycemic Agents Phase 3
5 Pharmaceutical Solutions Phase 3
6 Ophthalmic Solutions Phase 3
7 Disinfectants Phase 3
8 Biguanides Phase 3
9 Anti-Infective Agents Phase 3
10 Antiparasitic Agents Phase 3
11 Antiprotozoal Agents Phase 3
12 Anti-Infective Agents, Local Phase 3
13
Methylprednisolone Approved, Vet_approved Phase 2 83-43-2 6741
14 Prednisolone acetate Approved, Vet_approved Phase 2 52-21-1
15
Methylprednisolone hemisuccinate Approved Phase 2 2921-57-5
16
Prednisolone Approved, Vet_approved Phase 2 50-24-8 5755
17
Povidone Approved Phase 2 9003-39-8
18
Prednisolone phosphate Approved, Vet_approved Phase 2 302-25-0
19
Povidone-iodine Approved Phase 2 25655-41-8
20
Iodine Approved, Investigational Phase 2 7553-56-2 807
21
Prednisolone hemisuccinate Experimental Phase 2 2920-86-7
22 Gastrointestinal Agents Phase 2
23 Trace Elements Phase 2
24 Antiemetics Phase 2
25 Anti-Inflammatory Agents Phase 2
26 Micronutrients Phase 2
27 Methylprednisolone Acetate Phase 2
28 Chlorhexidine gluconate Phase 2
29 Nutrients Phase 2
30 Protective Agents Phase 2
31 Dermatologic Agents Phase 2
32 Neuroprotective Agents Phase 2
33 glucocorticoids Phase 2
34 Hormone Antagonists Phase 2
35 Antineoplastic Agents, Hormonal Phase 2
36 Lubricant Eye Drops Phase 2
37 Autonomic Agents Phase 2
38 cadexomer iodine Phase 2
39 Blood Substitutes Phase 2
40 Plasma Substitutes Phase 2
41 Hormones Phase 2
42
Dexamethasone acetate Approved, Investigational, Vet_approved 1177-87-3
43
Tacrolimus Approved, Investigational 104987-11-3 445643 439492 6473866
44
Dexamethasone Approved, Investigational, Vet_approved 50-02-2 5743
45
Tobramycin Approved, Investigational 32986-56-4 36294 5496
46 Immunologic Factors
47 Tobramycin, Dexamethasone Drug Combination
48 Immunosuppressive Agents
49 Anti-Bacterial Agents
50 Calcineurin Inhibitors
51 BB 1101

Interventional clinical trials:

(showing 7, show less)
# Name Status NCT ID Phase Drugs
1 Randomized, Active-Controlled, Phase 3 Study to Evaluate Efficacy, Safety and Tolerability of 0.08% PHMB Ophthalmic Solution in Comparison With 0.02% PHMB + 0.1% Propamidine Combination Therapy in Subjects Affected by Acanthamoeba Keratitis Recruiting NCT03274895 Phase 3 PHMB 0.08%;Propamidine 0.1%;placebo;PHMB 0.02%
2 Parasitic Ulcer Treatment Trial Pilot Recruiting NCT03484507 Phase 2 Chlorhexidine;Povidone-Iodine;Prednisolone Sodium Phosphate;Hydroxypropyl Methylcellulose;Prednisolone Sodium Phosphate;Hydroxypropyl Methylcellulose
3 Randomized, Double-Masked, Placebo-Controlled Multiple-Dose Phase 1 Study to Evaluate the Safety and Tolerability of Different Doses of Preservative-free Polyhexamethylene Biguanide (PHMB) Ophthalmic Solution in Healthy Subjects Completed NCT02506257 Phase 1 0.04% PHMB;0.06% PHMB;0.08% PHMB;PHMB Vehicle
4 Retrospective Study of the in Vivo Confocal Microscopic Findings and the Treatment Outcome of Acanthamoebic Keratitis Unknown status NCT02763605
5 Prospective Study of Deep Anterior Lamellar Keratoplasty Using Acellular Porcine Cornea Recruiting NCT03105466 Tacrolimus eye drops;Tobradex eyedrops
6 Microbiologic Alterations of the Conjunctiva of Hot Tub-soaking Ophthalmologists Recruiting NCT03987178
7 Ultrahigh-resolution Optical Coherence Tomography Imaging of the Anterior Eye Segment Structures - a Pilot Study Enrolling by invitation NCT03461978

Search NIH Clinical Center for Acanthamoeba Keratitis

Inferred drug relations via UMLS 71 / NDF-RT 50 :


Ketoconazole

Genetic Tests for Acanthamoeba Keratitis

Anatomical Context for Acanthamoeba Keratitis

MalaCards organs/tissues related to Acanthamoeba Keratitis:

40
Eye, Testes, Skin, Retina, Thymus, Brain, Cortex

Publications for Acanthamoeba Keratitis

Articles related to Acanthamoeba Keratitis:

(showing 1069, show less)
# Title Authors PMID Year
1
Oral miltefosine for refractory Acanthamoeba keratitis. 61
31650083 2019
2
Resolution of Acanthamoeba Keratitis with Adjunctive Use of Oral Miltefosine. 61
31829774 2019
3
Therapeutic penetrating keratoplasty for acanthamoeba keratitis: a review of cases, complications and predictive factors. 61
31214859 2019
4
Role of in vivo confocal microscopy in the diagnosis of infectious keratitis. 61
31209694 2019
5
Antimicrobial Photodynamic Therapy with the photosensitizer TONS504 eradicates Acanthamoeba. 61
31499180 2019
6
Extracellular protease profile of Acanthamoeba after prolonged axenic culture and after interaction with MDCK cells. 61
31848745 2019
7
Histone Deacetylase Inhibitors Enhance the Amoebicidal Effect of Low Concentration of Polyhexamethylene Biguanide by Inducing Apoptosis. 61
31724982 2019
8
Epipremnum aureum Keratopathy: Case Report and Review of the Literature. 61
31794541 2019
9
[Acanthamoeba endophthalmitis-a case report]. 61
31768616 2019
10
Synergy Testing of Antiamoebic Agents for Acanthamoeba: Antagonistic Effect of Voriconazole. 61
31306283 2019
11
Analysis from a year of increased cases of Acanthamoeba Keratitis in a large teaching hospital in the UK. 61
31018907 2019
12
The role of extracellular matrix in mouse and human corneal neovascularization. 61
31582785 2019
13
Therapeutic penetrating keratoplasty for microbial keratitis in Taiwan from 2001 to 2014. 61
31635845 2019
14
The First Acanthamoeba keratitis Case of Non-Contact Lens Wearer with HIV Infection in Thailand. 61
31715691 2019
15
Early Penetrating Keratoplasty À Chaud May Improve Outcome in Therapy-Resistant Acanthamoeba Keratitis. 61
31317392 2019
16
Acanthamoeba keratitis related to contact lens use in a tertiary hospital in China. 61
31533675 2019
17
High fluence PACK-CXL as adjuvant treatment for advanced Acanthamoeba keratitis. 61
31312750 2019
18
Acanthamoeba keratitis in Australia: demographics, associated factors, presentation and outcomes: a 15-year case review. 61
31554948 2019
19
Clinical course of Acanthamoeba keratitis by genotypes T4 and T8 in Hungary. 61
30835133 2019
20
Contact Lens Versus Non-Contact Lens-Related Corneal Ulcers at an Academic Center. 61
31442212 2019
21
Corticosteroid eye drop instillation aggravates the development of Acanthamoeba keratitis in rabbit corneas inoculated with Acanthamoeba and bacteria. 61
31492880 2019
22
Acanthamoeba keratitis therapy: time to cure and visual outcome analysis for different antiamoebic therapies in 227 cases. 61
31401556 2019
23
Reduction of Acanthamoeba Cyst Density Associated With Treatment Detected by In Vivo Confocal Microscopy in Acanthamoeba Keratitis. 61
31169613 2019
24
[Diagnostic value of fungal fluorescence staining on corneal scrapings for fungal keratitis]. 61
31422639 2019
25
Efficient therapeutic effect of Nigella sativa aqueous extract and chitosan nanoparticles against experimentally induced Acanthamoeba keratitis. 61
31144032 2019
26
Effectiveness of sampling methods employed for Acanthamoeba keratitis diagnosis by culture. 61
29916123 2019
27
Clinical features and serial changes of Acanthamoeba keratitis: an in vivo confocal microscopy study. 61
31292523 2019
28
Oral Miltefosine as Adjunctive Treatment for Recalcitrant Acanthamoeba Keratitis. 61
31170106 2019
29
Acanthamoeba Keratitis. 61
31314971 2019
30
Corneal Endotheliitis as a Presentation of Acanthamoeba Keratitis. 61
31219868 2019
31
Water Exposure and the Risk of Contact Lens-Related Disease. 61
30789440 2019
32
Synthesis and in vitro activity of new biguanide-containing dendrimers on pathogenic isolates of Acanthamoeba polyphaga and Acanthamoeba griffini. 61
31069536 2019
33
Cobalt nanoparticles as novel nanotherapeutics against Acanthamoeba castellanii. 61
31159839 2019
34
Torn from the headlines: role of public awareness and bench- to-bedside research in prevention and treatment of Acanthamoeba keratitis. 61
30552420 2019
35
Notes from the Field: Acanthamoeba Keratitis Cases - Iowa, 2002-2017. 61
31095535 2019
36
[Infectious keratitis in contact lens wearers]. 61
31120209 2019
37
The Acanthamoeba-Fungal Keratitis Study. 61
30721687 2019
38
Efficacy of Topical Miltefosine in Patients with Acanthamoeba Keratitis: A Pilot Study. 61
30572075 2019
39
Clinical features and outcomes of Acanthamoeba keratitis in a tertiary hospital over 20- year period. 61
31076316 2019
40
Reduction of Acanthamoeba Cyst Density Associated With Treatment Detected by In Vivo Confocal Microscopy in Acanthamoeba Keratitis. 61
30640249 2019
41
Tear Inflammatory Molecules in Contact Lens Wearers: A Literature Review. 61
30963963 2019
42
Evidence of human-like Ca2+ channels and effects of Ca2+ channel blockers in Acanthamoeba castellanii. 61
30362253 2019
43
Accelerated collagen cross-linking in the management of advanced Acanthamoeba keratitis. 61
30726402 2019
44
Drug targeting in Acanthamoeba keratitis: rational of using drugs that are already approved for ocular use in non-keratitis indications. 61
30356128 2019
45
Acanthamoeba keratitis - Clinical signs, differential diagnosis and treatment. 61
30899841 2019
46
Dual 0.02% chlorhexidine digluconate - 0.1% disodium EDTA loaded thermosensitive ocular gel for Acanthamoeba keratitis treatment. 61
30553004 2019
47
Outcomes of therapeutic keratoplasty for severe infectious keratitis in Chongqing, a 16-year experience. 61
31496763 2019
48
Reactive uveitis, retinal vasculitis and scleritis as ocular end-stage of Acanthamoeba keratitis: a histological study. 61
31850183 2019
49
Genotypic diversity of Acanthamoeba strains isolated from Chilean patients with Acanthamoeba keratitis. 61
30683157 2019
50
Acanthamoeba Keratitis: Current Status and Urgent Research Priorities. 61
29745319 2019
51
The rising incidence of Acanthamoeba keratitis: A 7-year nationwide survey and clinical assessment of risk factors and functional outcomes. 61
31491000 2019
52
Box Behnken design of siRNA-loaded liposomes for the treatment of a murine model of ocular keratitis caused by Acanthamoeba. 61
30384269 2019
53
Acanthamoeba keratitis in Mexico: Report of a clinical case and importance of sensitivity assays for a better outcome. 61
30472333 2019
54
Evaluation of in vitro effects of selected physical and chemical agents on detected in Poland Acanthamoeba strains – factors of increasing threats for public health 61
31095904 2019
55
Comparison of Proteins Secreted into Extracellular Space of Pathogenic and Non-pathogenic Acanthamoeba castellanii. 61
30630275 2018
56
Effect of povidone iodine, chlorhexidine digluconate and toyocamycin on amphizoic amoebic strains, infectious agents of <i>Acanthamoeba</i> keratitis - a growing threat to human health worldwide. 61
30586959 2018
57
Total necrosis of cornea, iris and crystalline lens with exposure of vitreous hyaloid face in the context of recalcitrant acanthamoeba keratitis. 61
30555975 2018
58
Acanthamoeba keratitis: confirmation of the UK outbreak and a prospective case-control study identifying contributing risk factors. 61
30232172 2018
59
[Early Diagnosis and Successful Medical Treatment of Acanthamoeba Keratitis]. 61
29723885 2018
60
Molecular Bioburden of the Lens Storage Case for Contact Lens-Related Keratitis. 61
30044251 2018
61
Pythium insidiosum and Acanthamoeba keratitis in a contact lens user. 61
30567163 2018
62
Corneal "Plaque" formation after anti-acanthamoeba therapy in acanthamoeba keratitis. 61
30355882 2018
63
Acanthamoeba Keratitis: Are Recent Cases More Severe? 61
29847494 2018
64
Tannic acid-modified silver nanoparticles as a novel therapeutic agent against Acanthamoeba. 61
30112674 2018
65
Molecular and biochemical characterization of key enzymes in the cysteine and serine metabolic pathways of Acanthamoeba castellanii. 61
30477573 2018
66
Intracorneal injection of a detachable hybrid microneedle for sustained drug delivery. 61
30267886 2018
67
A report of 10 patients with Acanthamoeba keratitis. 61
29885816 2018
68
Acanthamoeba keratitis in 194 patients: risk factors for bad outcomes and severe inflammatory complications. 61
29298778 2018
69
Risk Factors for Acanthamoeba Keratitis-A Multistate Case-Control Study, 2008-2011. 61
28099282 2018
70
Acanthamoeba keratitis: An emerging disease among microbial keratitis in the Cap Bon region of Tunisia. 61
29859227 2018
71
Herpes simplex virus keratitis mimicking Acanthamoeba keratitis: a clinicopathological correlation. 61
30232207 2018
72
In Vitro Amoebicidal Activity of Titanium Dioxide/UV-A Combination Against Acanthamoeba. 61
30242357 2018
73
Production of a monoclonal antibody against a mannose-binding protein of Acanthamoeba culbertsoni and its localization. 61
30031120 2018
74
The first Acanthamoeba keratitis case in the Midwest region of Brazil: diagnosis, genotyping of the parasite and disease outcome. 61
30304286 2018
75
The rising tide of Acanthamoeba keratitis in Auckland, New Zealand: a 7-year review of presentation, diagnosis and outcomes (2009-2016). 61
29412494 2018
76
Prevention of Acanthamoeba keratitis in contact lens wearers: is the message getting through? 61
30133903 2018
77
Epidemiology, risk factors, and clinical outcomes in severe microbial keratitis in South India. 61
29580152 2018
78
Treatment of intraocular spread of acanthamoeba after tectonic corneal graft in acanthamoeba keratitis. 61
29472699 2018
79
Factors Influencing the Diagnostic Accuracy of Laser-Scanning In Vivo Confocal Microscopy for Acanthamoeba Keratitis. 61
29303889 2018
80
Effect of Nitric Oxide on Acanthamoeba castellanii. 61
29971441 2018
81
Evaluation of voriconazole anti-Acanthamoeba polyphaga in vitro activity, rat cornea penetration and efficacy against experimental rat Acanthamoeba keratitis. 61
29596605 2018
82
[Isolation of Balamuthia mandriallaris parasite from air conditioning of the houses in south and southeast of Turkey]. 61
30156514 2018
83
Orbital implant exposure after Acanthamoeba panophthalmitis. 61
29780912 2018
84
Presence of Acanthamoeba in the ocular surface in a Spanish population of contact lens wearers. 61
29654681 2018
85
Virulent T4 Acanthamoeba causing keratitis in a patient after swimming while wearing contact lenses in Southern Brazil. 61
29654672 2018
86
Acanthamoeba in the eye, can the parasite hide even more? Latest developments on the disease. 61
29273391 2018
87
Toxic effects of selected proprietary dry eye drops on Acanthamoeba. 61
29867132 2018
88
In Vivo Confocal Microscopy Cellular Features of Host and Organism in Bacterial, Fungal, and Acanthamoeba Keratitis. 61
29550185 2018
89
Acanthamoeba keratitis in patients wearing scleral contact lenses. 61
29221710 2018
90
Risk factors, demographics and clinical profile of Acanthamoeba keratitis in Melbourne: an 18-year retrospective study. 61
28844988 2018
91
Acanthamoeba keratitis in noncompliant soft contact lenses users: Genotyping and risk factors, a study from Cairo, Egypt. 61
28965795 2018
92
Tap Water and Risk of Acanthamoeba Keratitis in Rigid Gas Permeable Lens Wearers: Sacred Cow or Culprit: Erratum. 61
29688957 2018
93
Chloroquine as a possible disinfection adjunct of disinfection solutions against Acanthamoeba. 61
29625097 2018
94
Comparison of In Vivo Confocal Microscopy, PCR and Culture of Corneal Scrapes in the Diagnosis of Acanthamoeba Keratitis. 61
29256983 2018
95
A survey of contact lens-related complications in a tertiary hospital in China. 61
29033270 2018
96
Case Report: Acanthamoeba Keratitis Management in a First-trimester Pregnant Patient. 61
29554009 2018
97
[Microbial keratitis - part 2: Specific aspects of mycotic and acanthamoeba keratitis]. 61
29490392 2018
98
First report of Acanthamoeba genotype T8 human keratitis. 61
29471697 2018
99
The use of miltefosine in the management of refractory Acanthamoeba keratitis. 61
29580956 2018
100
Acanthamoeba keratitis in Porto Alegre (southern Brazil): 28 cases and risk factors. 61
29332157 2018
101
Tap Water and Risk of Acanthamoeba Keratitis in Rigid Gas-Permeable Lens Wearers: Sacred Cow or Culprit? 61
29462055 2018
102
High-resolution, label-free two-photon imaging of diseased human corneas. 61
29500874 2018
103
Apoptosis of Acanthamoeba castellanii Trophozoites Induced by Oleic Acid. 61
28787535 2018
104
Assessment of Confocal Microscopy for the Diagnosis of Polymerase Chain Reaction-Positive Acanthamoeba Keratitis: A Case-Control Study. 61
28965660 2018
105
Comparison of chlorhexidine disinfectant in vitro effect on environmental and ocular Acanthamoeba strains, the amoebic agents of human keratitis − an emerging sight-threatening corneal disease in Poland 61
30316219 2018
106
Amoebas from the genus Acanthamoeba and their pathogenic properties 61
30720249 2018
107
[A new strategy for enhancing acanthamoebicidal activity with synthesis of nanoflower of Laurocerausus officinalis Roemer (cherry laurel) fruit extracts]. 61
29642830 2018
108
Stability of an ophthalmic formulation of polyhexamethylene biguanide in gamma-sterilized and ethylene oxide sterilized low density polyethylene multidose eyedroppers. 61
29682408 2018
109
Expert practice patterns and opinions on corneal cross-linking for infectious keratitis. 61
29657977 2018
110
Effect of ethanol pretreatment in Acanthamoeba keratitis: a long-term follow-up study. 61
30013376 2018
111
Regional spread of contact lens-related Acanthamoeba keratitis in Italy. 61
29505068 2018
112
Can artificial tears prevent Acanthamoeba keratitis? An in vitro approach. 61
29357901 2018
113
Confocal microscopy as an early relapse marker for acanthamoeba keratitis. 61
28556202 2018
114
Risk factors and clinical signs of severe Acanthamoeba keratitis. 61
30573947 2018
115
Comparison of anterior segment optical coherence tomography findings in acanthamoeba keratitis and herpetic epithelial keratitis. 61
30140650 2018
116
Risk factors and clinical features of Acanthamoeba keratitis in a Tunisian tertiary eye care center. 61
28964757 2017
117
Failure of molecular diagnostics of a keratitis-inducing Acanthamoeba strain. 61
28919334 2017
118
Effect of Multipurpose Solution Combined With Autophagy Inhibitors on Adhesion of Acanthamoeba trophozoites to Silicone Hydrogel Contact Lenses. 61
28834815 2017
119
Correlation of radical-scavenging capacity and amoebicidal activity of Matricaria recutita L. (Asteraceae). 61
28919332 2017
120
Acute keratoconjunctivitis due to contamination of contact lens care solution with histamine-producing Raoultella species: A case report. 61
29390396 2017
121
In vitro amoebicidal and antioxidant activities of some Tunisian seaweeds. 61
29102681 2017
122
Evaluation of the anti-Acanthamoeba activity of two commercial eye drops commonly used to lower eye pressure. 61
28778743 2017
123
First time identification of Acanthamoeba genotypes in the cornea samples of wild birds; Is Acanthamoeba keratitis making the predatory birds a target? 61
28807756 2017
124
Acanthamoeba-mediated cytopathic effect correlates with MBP and AhLBP mRNA expression. 61
29282148 2017
125
In vitro activity of 1H-phenalen-1-one derivatives against Acanthamoeba castellanii Neff and their mechanisms of cell death. 61
28916457 2017
126
Sensitivity of Enzymatic Toxins from Corneal Isolate of Acanthamoeba Protozoan to Physicochemical Parameters. 61
28755026 2017
127
Non-contact lens related Acanthamoeba keratitis. 61
29133630 2017
128
Rapid resolution of stromal keratitis with the assistance of oral voriconazole in resistant acanthamoeba keratitis. 61
29296556 2017
129
Associated factors, diagnosis and management of Acanthamoeba keratitis in a referral Center in Southern China. 61
28969610 2017
130
Evaluation of In Vitro Antiamoebic Activity of Antimicrobial Agents Against Clinical Acanthamoeba Isolates. 61
28704121 2017
131
Characterizing clinical isolates of Acanthamoeba castellanii with high resistance to polyhexamethylene biguanide in Taiwan. 61
26698685 2017
132
Molecular and morphological characterization of Acanthamoeba isolated from corneal scrapes and contact lens wearers in Argentina. 61
28676340 2017
133
siRNA-loaded liposomes: Inhibition of encystment of Acanthamoeba and toxicity on the eye surface. 61
28135787 2017
134
Number of Bacteria and Time of Coincubation With Bacteria Required for the Development of Acanthamoeba Keratitis. 61
28691946 2017
135
In-vitro development of an effective treatment for Acanthamoeba keratitis. 61
28709990 2017
136
[Diagnostics and treatment of infectious keratitis]. 61
28758436 2017
137
Quantitative Analysis of Depth, Distribution, and Density of Cysts in Acanthamoeba Keratitis Using Confocal Microscopy. 61
28542085 2017
138
Characterisation of sterol biosynthesis and validation of 14α-demethylase as a drug target in Acanthamoeba. 61
28811501 2017
139
Water Exposure is a Common Risk Behavior Among Soft and Gas-Permeable Contact Lens Wearers. 61
28410356 2017
140
[Good outcome in Acanthamoeba keratitis]. 61
27558689 2017
141
Tear Cytokine Levels in Contact Lens Wearers With Acanthamoeba Keratitis. 61
28489721 2017
142
Pathobiology and Immunobiology of Acanthamoeba Keratitis: Insights from Animal Models
. 61
28656012 2017
143
Results with the Boston Type I keratoprosthesis after Acanthamoeba keratitis. 61
29260063 2017
144
Cytoarchitecture of epithelial inflammatory infiltration indicates the aetiology of infectious keratitis. 61
28371196 2017
145
Human infections caused by free-living amoebae. 61
28664704 2017
146
In Vitro Evaluation of the Ophthalmic Toxicity Profile of Chlorhexidine and Propamidine Isethionate Eye Drops. 61
28384032 2017
147
Nanoemulsions Containing a Coumarin-Rich Extract from Pterocaulon balansae (Asteraceae) for the Treatment of Ocular Acanthamoeba Keratitis. 61
27225384 2017
148
Molecular diagnosis of Acanthamoeba keratitis: evaluation in rat model and application in suspected human cases. 61
28251314 2017
149
ACANTHAMOEBA ENDOPHTHALMITIS AFTER RECURRENT KERATITIS AND NODULAR SCLERITIS. 61
27152698 2017
150
Painless Acanthamoeba Keratitis with Normal Vision. 61
27870779 2017
151
Corneal Higher-Order Aberrations in Infectious Keratitis. 61
28040524 2017
152
Number of Bacteria and Time of Coincubation With Bacteria Required for the Development of Acanthamoeba Keratitis. 61
28079686 2017
153
Therapeutic agents and biocides for ocular infections by free-living amoebae of Acanthamoeba genus. 61
27836717 2017
154
Topical Coenzyme Q10 Eye Drops as an Adjuvant Treatment in Challenging Refractory Corneal Ulcers: A Case Series and Literature Review. 61
26783983 2017
155
Evaluation of the effectiveness of tea tree oil in treatment of Acanthamoeba infection. 61
28124137 2017
156
Effects of lactoferrin on the viability and the encystment of Acanthamoeba trophozoites. 61
28140621 2017
157
Ultrahigh-resolution OCT imaging of the human cornea. 61
28271013 2017
158
Dacryoadenitis and extraocular muscle inflammation associated with contact lens-related Acanthamoeba keratitis: A case report and review of the literature. 61
27874294 2017
159
A Rabbit Model of Acanthamoeba Keratitis: Use of Infected Soft Contact Lenses After Corneal Epithelium Debridement With a Diamond Burr. 61
28241309 2017
160
Keratoneuritis is not pathognomonic of Acanthamoeba keratitis: a case report of Pseudomonas keratitis. 61
27003712 2017
161
Specificity of in vivo confocal cornea microscopy in Acanthamoeba keratitis. 61
27312210 2017
162
A case of non-Acanthamoeba keratitis with radial keratoneuritis. 61
28861362 2017
163
Severe reactive ischemic posterior segment inflammation in Acanthamoeba keratitis: Case report of a patient with Sjögren's syndrome. 61
28386159 2017
164
Evaluation of loop-mediated isothermal amplification assay for rapid diagnosis of Acanthamoeba keratitis. 61
28303825 2017
165
The Relation of Ocular Surface Irregularity and Visual Disturbance in Early Stage Acanthamoeba Keratitis. 61
26783979 2017
166
In vivo confocal microscopy and in vitro culture techniques as tools for evaluation of severe Acanthamoeba keratitis incidents 61
29420872 2017
167
Amoebicidal or amoebostatic influence of disinfectants used in health facilities and laboratories on corneal strains of Acanthamoeba 61
29274209 2017
168
Free-living amoebae isolated in the Central African Republic: epidemiological and molecular aspects. 61
28451034 2017
169
Programmed cell death in Acanthamoeba castellanii Neff induced by several molecules present in olive leaf extracts. 61
28859105 2017
170
Role of fatty acid salts as anti Acanthamoeba agents for disinfecting contact lens. 61
28954958 2017
171
Adhesion forces and mechanics in mannose-mediated acanthamoeba interactions. 61
28472161 2017
172
Isolation and molecular characterization of Acanthamoeba genotypes isolated from soil sources of public and recreational areas in Iran. 61
27787217 2016
173
Effects of Lead Phytochemicals of Radix Scutellariae on Acanthamoeba. 61
27918833 2016
174
Molecular detection and genotyping of Acanthamoeba spp. among stray dogs using conjunctival swab sampling. 61
27545086 2016
175
The effect of the disulfideisomerase domain containing protein in the defense against polyhexamethylene biguanide of highly tolerant Acanthamoeba at the trophozoite stage. 61
27888770 2016
176
The role of oral co-trimoxazole in treating Nocardia farcinica keratitis-a case report. 61
27324239 2016
177
The role of oral co-trimoxazole in treating Nocardia farcinica keratitis: a case report. 61
27294730 2016
178
The Development of Drugs against Acanthamoeba Infections. 61
27600042 2016
179
Microwave Irradiation as a Promising Method of Sterilization for Acanthamoeba polyphaga in Cultures. 61
27467043 2016
180
Toll-like receptors in the brain of mice following infection with Acanthamoeba spp. 61
27511368 2016
181
[Investigation of the in vitro effects of Melissa officinalis L., Mentha x piperita L. and Ocimum basilicum L. (Lamiaceae) essential oils on the cysts and trophozoites of Acanthamoeba castellani]. 61
28124962 2016
182
The use of dimethyl sulfoxide in contact lens disinfectants is a potential preventative strategy against contracting Acanthamoeba keratitis. 61
27133448 2016
183
Comparison of In Vivo Confocal Microscopy, Ultrasonic Pachymetry, and Scheimpflug Topography for Measuring Central Corneal Thickness. 61
27415451 2016
184
Effect of non-steroidal anti-inflammatory drugs on biological properties of Acanthamoeba castellanii belonging to the T4 genotype. 61
27381503 2016
185
Isolation and molecular characterization of Acanthamoeba strains isolated from the oral cavity of immunosuppressed individuals in Tehran, Iran. 61
27447206 2016
186
Laboratory diagnosis of Acanthamoeba keratitis in Hungary. 61
27576919 2016
187
Isolation and genotyping of Acanthamoeba strains (T4, T9, and T11) from amoebic keratitis patients in Iran. 61
27102637 2016
188
Acanthamoeba Keratitis among Rigid Gas Permeable Contact Lens Wearers in the United States, 2005 through 2011. 61
27117780 2016
189
[Keratitis - Infectious or Autoimmune?]. 61
27468096 2016
190
Comparative proteomic analysis of extracellular secreted proteins expressed by two pathogenic Acanthamoeba castellanii clinical isolates and a non-pathogenic ATCC strain. 61
26995533 2016
191
In vitro anti-Acanthamoeba synergistic effect of chlorhexidine and cationic carbosilane dendrimers against both trophozoite and cyst forms. 61
27173821 2016
192
Acanthamoeba infection in lungs of mice expressed by toll-like receptors (TLR2 and TLR4). 61
26940205 2016
193
Regulatory Impact of Amniotic Membrane Transplantation on Presence of Adhesion/Growth-Regulatory Galectins-1 and -7 in Corneal Explants from Acanthamoeba Keratitis Patients: Clinical Note. 61
26338079 2016
194
Early Deep Anterior Lamellar Keratoplasty (DALK) for Acanthamoeba Keratitis-How to Define Early? 61
27032028 2016
195
Update on Acanthamoeba Keratitis: Diagnosis, Treatment, and Outcomes. 61
26989955 2016
196
Genotyping of Acanthamoeba spp. and characterization of the prevalent T4 type along with T10 and unassigned genotypes from amoebic keratitis patients in India. 61
26887324 2016
197
Detection of Balamuthia mandrillaris DNA in the storage case of contact lenses in Germany. 61
26965426 2016
198
The Impact of Topical Corticosteroids Used in Conjunction with Antiamoebic Therapy on the Outcome of Acanthamoeba Keratitis. 61
26952591 2016
199
Genotypic, physiological, and biochemical characterization of potentially pathogenic Acanthamoeba isolated from the environment in Cairo, Egypt. 61
26841771 2016
200
Determination of cytotoxicity of traditional Chinese medicine herbs, Rhizoma coptidis, Radix scutellariae, and Cortex phellodendri, by three methods. 61
26421730 2016
201
Management of inflammatory corneal melt leading to central perforation in children: a retrospective study and review of literature. 61
26821761 2016
202
A Multiplex Dot Hybridization Assay For Detection and Differentiation of Acanthamoeba and Herpes Keratitis. 61
27111562 2016
203
Strategies for the prevention of contact lens-related Acanthamoeba keratitis: a review. 61
26691018 2016
204
Effects of multipurpose solutions on the adhesion of Acanthamoeba to rigid gas permeable contact lenses. 61
26890700 2016
205
Clinical evaluation and characterisation of corneal vascularisation. 61
26163540 2016
206
Dendritiform Keratopathy Associated with Exposure to Polyquarternium-1, a Common Ophthalmic Preservative. 61
26686962 2016
207
Acanthamoeba genotypes T3 and T4 as causative agents of amoebic keratitis in Mexico. 61
26581373 2016
208
Acanthamoeba keratitis associated with intracorneal hydrogel inlay. 61
26563837 2016
209
Acanthamoeba keratitis challenges a case report. 61
27220232 2016
210
A novel antiamoebic agent against Acanthamoeba sp.--A causative agent for eye keratitis infection. 61
26474244 2016
211
[Diagnosis of Acanthamoeba keratitis]. 61
28635734 2016
212
[Treatment of Acanthamoeba keratitis]. 61
28635735 2016
213
Crosslinking and corneal cryotherapy in acanthamoeba keratitis -- a histological study. 61
26483144 2016
214
The Value of Cytology Smears for Acanthamoeba Keratitis. 61
27403362 2016
215
Early Deep Anterior Lamellar Keratoplasty (DALK) for Acanthamoeba Keratitis Poorly Responsive to Medical Treatment. 61
26562819 2016
216
Corneal infection in Shandong peninsula of China: a 10-year retrospective study on 578 cases. 61
26949610 2016
217
Risk factors for visual impairment associated with corneal diseases in southern China. 61
27194904 2016
218
Characterisation and expression analysis of trophozoite and cyst proteins of Acanthamoeba spp. isolated from Acanthamoeba keratitis (AK) patient. 61
27030419 2016
219
Assessment of in vitro dynamics of pathogenic Acanthamoeba strains originating from contact lens wearers with infectious keratitis 61
28170206 2016
220
Acanthamoeba spp. in Contact Lenses from Healthy Individuals from Madrid, Spain. 61
27105183 2016
221
Formulation and stability of an extemporaneous 0.02% chlorhexidine digluconate ophthalmic solution. 61
25260549 2015
222
Contact lens care solution killing efficacy against Acanthamoeba castellanii by in vitro testing and live-imaging. 61
26208952 2015
223
Gold Nanoparticle Conjugation Enhances the Antiacanthamoebic Effects of Chlorhexidine. 61
26666949 2015
224
Autofluorescence Signatures of Seven Pathogens: Preliminary in Vitro Investigations of a Potential Diagnostic for Acanthamoeba Keratitis. 61
26488626 2015
225
Potential Value of Cellulose Synthesis Inhibitors Combined With PHMB in the Treatment of Acanthamoeba Keratitis. 61
26426333 2015
226
[Erratum to: The German Acanthamoeba keratitis register : Initial results of a multicenter study]. 61
26441319 2015
227
Comparison of Validated Polymerase Chain Reaction and Culture Isolation for the Routine Detection of Acanthamoeba From Ocular Samples. 61
25839345 2015
228
Contralateral Clinically Unaffected Eyes of Patients With Unilateral Infectious Keratitis Demonstrate a Sympathetic Immune Response. 61
26465889 2015
229
Investigation of the Role of Bacteria in the Development of Acanthamoeba Keratitis. 61
26203748 2015
230
[The German Acanthamoeba keratitis register: Initial results of a multicenter study]. 61
25833754 2015
231
The role of domestic tap water on Acanthamoeba keratitis in non-contact lens wearers and validation of laboratory methods. 61
26017346 2015
232
[The Investigation of Acanthamoeba and Other Free Living Amoeba in Swab Samples Obtained from Conjunctiva and Eye Lid]. 61
26470924 2015
233
Ophthalmology hospital wards contamination to pathogenic free living Amoebae in Iran. 61
26204177 2015
234
Artemether Exhibits Amoebicidal Activity against Acanthamoeba castellanii through Inhibition of the Serine Biosynthesis Pathway. 61
26014935 2015
235
Contact Lens Wearer Demographics and Risk Behaviors for Contact Lens-Related Eye Infections--United States, 2014. 61
26292204 2015
236
Detection of Acanthamoeba on the ocular surface in a Spanish population using the Schirmer strip test: pathogenic potential, molecular classification and evaluation of the sensitivity to chlorhexidine and voriconazole of the isolated Acanthamoeba strains. 61
26293786 2015
237
Comparison of Fluorescence Microscopy and Different Growth Media Culture Methods for Acanthamoeba Keratitis Diagnosis. 61
25962772 2015
238
A Rabbit Model of Acanthamoeba Keratitis That Better Reflects the Natural Human Infection. 61
25766300 2015
239
Acanthamoeba keratitis: improving the Scottish diagnostic service for the rapid molecular detection of Acanthamoeba species. 61
25976006 2015
240
Contact Lens-Related Acanthamoeba Keratitis and Accompanying Dacryoadenitis. 61
25603441 2015
241
Clinico-microbiological review of non-contact-lens-associated acanthamoeba keratitis. 61
24251436 2015
242
Autophagy inhibitors as a potential antiamoebic treatment for Acanthamoeba keratitis. 61
25896709 2015
243
Chlorhexidine Monotherapy with Adjunctive Topical Corticosteroids for Acanthamoeba Keratitis. 61
26425310 2015
244
Acanthamoeba keratitis: clinical characteristics and management. 61
25881999 2015
245
Acanthamoeba keratitis: 10-year study at a tertiary eye care center in Hong Kong. 61
25496910 2015
246
Use of multiple immunosuppressive agents in recalcitrant ACANTHAMOEBA scleritis. 61
25878227 2015
247
Several staining techniques to enhance the visibility of Acanthamoeba cysts. 61
25346196 2015
248
[Evaluation of in vitro efficacy of combined riboflavin and ultraviolet-A (365 nm) for Acanthamoeba]. 61
25637236 2015
249
Genotypic characterization of amoeba isolated from Acanthamoeba keratitis in Poland. 61
25604673 2015
250
Medical interventions for acanthamoeba keratitis. 61
25710134 2015
251
Evaluation of the activity of new cationic carbosilane dendrimers on trophozoites and cysts of Acanthamoeba polyphaga. 61
25358240 2015
252
Identifying differentially expressed genes in trophozoites and cysts of Acanthamoeba T4 genotype: Implications for developing new treatments for Acanthamoeba keratitis. 61
25543551 2015
253
Therapeutic and optical keratoplasty in the management of Acanthamoeba keratitis: risk factors, outcomes, and summary of the literature. 61
25262318 2015
254
Amniotic membrane graft to conjunctival flap in treatment of non-viral resistant infectious keratitis: a randomised clinical study. 61
25053758 2015
255
Emerging Threats for Human Health in Poland: Pathogenic Isolates from Drug Resistant Acanthamoeba Keratitis Monitored in terms of Their In Vitro Dynamics and Temperature Adaptability. 61
26682216 2015
256
Treatment of Acanthamoeba neurotrophic corneal ulcer with topical matrix therapy. 61
26101555 2015
257
Cytotoxic activity and degradation patterns of structural proteins by corneal isolates of Acanthamoeba spp. 61
25161076 2015
258
IL-17A-mediated protection against Acanthamoeba keratitis. 61
25505284 2015
259
Treatment of acanthamoeba keratitis with intravenous pentamidine before therapeutic keratoplasty. 61
25255139 2015
260
An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment. 61
25687209 2015
261
Development of an immunochromatographic assay kit using fluorescent silica nanoparticles for rapid diagnosis of Acanthamoeba keratitis. 61
25392356 2015
262
Clinical Course of Unilateral Acanthamoeba Keratitis in a Cosmetic Contact Lens Wearer. 61
26116606 2015
263
Temperature limitation may explain the containment of the trophozoites in the cornea during Acanthamoeba castellanii keratitis. 61
25204727 2014
264
Acanthamoeba sclerokeratitis: epidemiology, clinical features, and treatment outcomes. 61
25097155 2014
265
PrestoBlue® and AlamarBlue® are equally useful as agents to determine the viability of Acanthamoeba trophozoites. 61
24703973 2014
266
Genotypic heterogeneity based on 18S-rRNA gene sequences among Acanthamoeba isolates from clinical samples in Italy. 61
24858926 2014
267
In vitro effects of selected contact lens care solutions on Acanthamoeba castellanii strains in Poland. 61
24967738 2014
268
Bioassay guided isolation and identification of anti-Acanthamoeba compounds from Tunisian olive leaf extracts. 61
24726697 2014
269
Amoebicidal efficacy of a novel multi-purpose disinfecting solution: first findings. 61
24858922 2014
270
Monitoring of in vitro dynamics of Acanthamoeba strains isolated from infected eyes as a useful tool in keratitis management. 61
24999093 2014
271
In vivo imaging of radial keratoneuritis in patients with Acanthamoeba keratitis by anterior-segment optical coherence tomography. 61
24935283 2014
272
Estimated burden of keratitis--United States, 2010. 61
25393221 2014
273
[Radial keratoneuritis imaging in a patient with Acanthamoeba keratitis]. 61
25199489 2014
274
[Acanthamoeba keratitis]. 61
25169145 2014
275
In vitro evaluations of topical agents to treat Acanthamoeba keratitis. 61
24880905 2014
276
Sitting at the window to the world--ocular parasites. 61
25358598 2014
277
Upper eyelid tarsoconjunctival flap for the treatment of Ahmed valve plate exposure. 61
24886759 2014
278
Acanthamoeba DNA can be directly amplified from corneal scrapings. 61
24951167 2014
279
Cysticidal activity of antifungals against different genotypes of Acanthamoeba. 61
25001304 2014
280
Acanthamoeba keratitis: a new normal. 61
25012982 2014
281
[Dynamic changes of serum antibody titer in a rabbit model of Acanthamoeba keratitis]. 61
25518604 2014
282
The impact of topical corticosteroid use before diagnosis on the outcome of Acanthamoeba keratitis. 61
24630688 2014
283
First report of an Acanthamoeba genotype T13 isolate as etiological agent of a keratitis in humans. 61
24802868 2014
284
Corneal cross-linking for Acanthamoeba keratitis in an orthokeratology patient after swimming in contaminated water. 61
24355444 2014
285
Acanthamoeba detection in the anterior chamber after therapeutic penetrating keratoplasty. 61
25120983 2014
286
Lethal effects of Helianthemum lippii (L.) on Acanthamoeba castellanii cysts in vitro. 61
25031463 2014
287
Protease-activated receptor 2 (PAR2) is upregulated by Acanthamoeba plasminogen activator (aPA) and induces proinflammatory cytokine in human corneal epithelial cells. 61
24876278 2014
288
Recommendations for the management of Acanthamoeba keratitis. 61
24509420 2014
289
Acanthamoeba keratitis - an increasing incidence. 61
24177033 2014
290
Prevalence of infectious keratitis in Central China. 61
24690368 2014
291
Influence of Acanthamoeba genotype on clinical course and outcomes for patients with Acanthamoeba keratitis in Spain. 61
24430449 2014
292
Anti-amoebic properties of carbonyl thiourea derivatives. 61
24759076 2014
293
Non-contact lens use-related Acanthamoeba keratitis in southern Turkey: evaluation of risk factors and clinical features. 61
24030538 2014
294
Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis. 61
23601234 2014
295
Fungal keratitis presenting as radial keratoneuritis. 61
24717856 2014
296
A new in vivo confocal microscopy prognostic factor in Acanthamoeba keratitis. 61
24398386 2014
297
Clinical characteristics of Acanthamoeba keratitis infections in 28 states, 2008 to 2011. 61
24322804 2014
298
Genotyping of potentially pathogenic Acanthamoeba strains isolated from nasal swabs of healthy individuals in Peru. 61
24140300 2014
299
Voriconazole as a first-line treatment against potentially pathogenic Acanthamoeba strains from Peru. 61
24265059 2014
300
The cyclic AMP phosphodiesterase RegA critically regulates encystation in social and pathogenic amoebas. 61
24184654 2014
301
Pathogenic strains of Acanthamoeba are recognized by TLR4 and initiated inflammatory responses in the cornea. 61
24633052 2014
302
In vitro efficacy of corifungin against Acanthamoeba castellanii trophozoites and cysts. 61
24366747 2014
303
Deep anterior lamellar keratoplasty for acanthamoeba keratitis complicating the use of Boston scleral lens. 61
24296954 2014
304
Acanthamoeba, fungal, and bacterial keratitis: a comparison of risk factors and clinical features. 61
24200232 2014
305
Failure of chemotherapy in the first reported cases of Acanthamoeba keratitis in Pakistan. 61
24548160 2014
306
[Survey of the number of Acanthamoeba keratitis cases in Japan]. 61
24505933 2014
307
[Issues in practice of Acanthamoeba keratitis]. 61
24505929 2014
308
Current advances in diagnostic methods of Acanthamoeba keratitis. 61
25189964 2014
309
[Acanthamoeba keratitis]. 61
24337209 2013
310
Pathological characteristics of the different stages of Acanthamoeba keratitis. 61
24079482 2013
311
Scleral and intraocular amoebic dissemination in Acanthamoeba keratitis. 61
23974886 2013
312
A year long study of the presence of free living amoeba in Spain. 61
24200005 2013
313
In vitro comparative assessment of different viability assays in Acanthamoeba castellanii and Acanthamoeba polyphaga trophozoites. 61
24026387 2013
314
Epithelial downgrowth after penetrating keratoplasty: imaging by high-resolution optical coherence tomography and in vivo confocal microscopy. 61
23928949 2013
315
The evaluation of the amebicidal activity of Eryngium planum extracts. 61
24383326 2013
316
Development of a practical complete-kill assay to evaluate anti-Acanthamoeba drugs. 61
24077460 2013
317
Rapid and sensitive diagnosis of Acanthamoeba keratitis by loop-mediated isothermal amplification. 61
23413965 2013
318
Acanthamoeba keratitis: study of the 5-year incidence in Israel. 61
23878134 2013
319
Profile of sight-threatening infectious keratitis: a prospective study. 61
22863376 2013
320
Utility of real-time PCR analysis for appropriate diagnosis for keratitis. 61
24104938 2013
321
Spontaneous lens extrusion: an unusual late complication of Acanthamoeba keratitis. 61
23456171 2013
322
Corneal Collagen Cross-Linking for the Treatment of Acanthamoeba Keratitis. 61
23974880 2013
323
Pathogenic assays of acanthamoeba belonging to the t4 genotype. 61
25516733 2013
324
[Clinical significance of modern methods of corneal assessment]. 61
24261277 2013
325
Evaluation of the in vitro activity of commercially available moxifloxacin and voriconazole eye-drops against clinical strains of Acanthamoeba. 61
23686225 2013
326
Presumed late recurrence of Acanthamoeba keratitis exacerbated by exposure to topical corticosteroids. 61
24391372 2013
327
Genetic characterization of clinical acanthamoeba isolates from Japan using nuclear and mitochondrial small subunit ribosomal RNA. 61
24039282 2013
328
Toxicity of topical ophthalmic anesthetics. 61
23617273 2013
329
Role of phospholipase A₂ (PLA₂) inhibitors in attenuating apoptosis of the corneal epithelial cells and mitigation of Acanthamoeba keratitis. 61
23792108 2013
330
In vivo laser confocal microscopy findings of radial keratoneuritis in patients with early stage Acanthamoeba keratitis. 61
23499062 2013
331
Impression cytology in eyes with clinical and confocal scan features of acanthamoeba keratitis. 61
24349663 2013
332
Acanthamoeba migration in an electric field. 61
23716626 2013
333
New insight into non-healing corneal ulcers: iatrogenic crystals. 61
23558213 2013
334
A systematic analysis of Acanthamoeba genotype frequency correlated with source and pathogenicity: T4 is confirmed as a pathogen-rich genotype. 61
23290304 2013
335
Effects of multipurpose solutions on the viability and encystment of acanthamoeba determined by flow cytometry. 61
23584044 2013
336
Acanthamoeba keratitis: a clinicopathologic case report and review of the literature. 61
23332929 2013
337
Co-isolation of Vahlkampfia and acanthamoeba in acanthamoeba-like keratitis in a Spanish population. 61
22929156 2013
338
Effect of low concentrations of benzalkonium chloride on acanthamoebal survival and its potential impact on empirical therapy of infectious keratitis. 61
23519403 2013
339
Misdiagnosis of orthokeratology-related Acanthamoeba keratitis as herpes simplex virus keratitis. 61
23231627 2013
340
Acanthamoeba keratitis. 61
23781754 2013
341
[Efficacy of Gram-Fungiflora Y double staining in diagnosing infectious keratitis]. 61
23767191 2013
342
Acanthamoeba keratitis: an emerging disease gathering importance worldwide? 61
23433689 2013
343
Isolation of Acanthamoeba from the rhizosphere of maize and lucerne plants. 61
23529297 2013
344
Acanthamoeba keratitis associated with tap water use during contact lens cleaning: manufacturer guidelines need to change. 61
23392300 2013
345
Rapid diagnosis of acanthamoeba keratitis using non-nutrient agar with a lawn of E. coli. 61
23514313 2013
346
Prognostic factors associated with the need for surgical treatments in acanthamoeba keratitis. 61
23132441 2013
347
Cytotoxic effect of acriflavine against clinical isolates of Acanthamoeba spp. 61
23052789 2013
348
[Evaluation of chemokines in tears of patients with infectious keratitis]. 61
23534256 2013
349
Treatment of Acanthamoeba keratitis by corneal cross-linking. 61
22929160 2013
350
[Delayed course of Acanthamoeba keratitis]. 61
23224124 2013
351
Acanthamoeba T4 genotype associated with keratitis infections in Tunisia. 61
23052779 2013
352
Raman microspectroscopy analysis in the treatment of acanthamoeba keratitis. 61
23977228 2013
353
Acanthamoeba keratitis: a 12-year experience covering a wide spectrum of presentations, diagnoses, and outcomes. 61
23840938 2013
354
Results of case-control studies support the association between contact lens use and Acanthamoeba keratitis. 61
23761962 2013
355
A case of medication-resistant acanthamoeba keratitis treated by corneal crosslinking in Turkey. 61
24455365 2013
356
Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and application of statins as a novel effective therapeutic approach against Acanthamoeba infections. 61
23114753 2013
357
Infections with free-living amebae. 61
23829906 2013
358
Diversity and seasonal impact of Acanthamoeba species in a subtropical rivershed. 61
24490160 2013
359
3. Ocular surface health with contact lens wear. 61
23347571 2013
360
Pathogenic free-living amoebae: epidemiology and clinical review. 61
22520593 2012
361
Acanthamoeba-cytopathic protein induces apoptosis and proinflammatory cytokines in human corneal epithelial cells by cPLA2α activation. 61
23132804 2012
362
Fluorescent labeling of Acanthamoeba assessed in situ from corneal sectioned microscopy. 61
23082290 2012
363
Effects of multipurpose contact lens care solutions on the adhesion of Acanthamoeba to silicone hydrogel contact lenses. 61
22673849 2012
364
Confoscan: an ideal therapeutic aid and screening tool in acanthamoeba keratitis. 61
23248549 2012
365
Mixed Acanthamoeba and multidrug-resistant Achromobacter xyloxidans in late-onset keratitis after laser in situ keratomileusis. 61
22999604 2012
366
Photochemotherapeutic strategies against Acanthamoeba keratitis. 61
22950898 2012
367
Painless Acanthamoeba keratitis. 61
22883850 2012
368
Acanthamoeba keratitis: the persistence of cases following a multistate outbreak. 61
22775278 2012
369
Molecular detection and comparison of Acanthamoeba genotypes in different functions of watersheds in Taiwan. 61
21800062 2012
370
Assessment of real-time polymerase chain reaction detection of Acanthamoeba and prognosis determinants of Acanthamoeba keratitis. 61
22381810 2012
371
Characteristics of an Acanthamoeba keratitis outbreak in British Columbia between 2003 and 2007. 61
22365067 2012
372
Prognostic factors in Acanthamoeba keratitis. 61
22687314 2012
373
[Acanthamoeba keratitis--a rare and often late diagnosed disease]. 61
22592343 2012
374
A one-step multiplex PCR for acanthamoeba keratitis diagnosis and quality samples control. 61
22427550 2012
375
Clinical features of Acanthamoeba keratitis in contact lens wearers and non-wearers. 61
23077833 2012
376
Effect of combined chlorhexidine gluconate and neosporin on experimental keratitis with two pathogenic strains of Acanthamoeba. 61
22160252 2012
377
New strategy for rapid diagnosis and characterization of keratomycosis. 61
22342013 2012
378
Isolation and identification of Acanthamoeba species from thermal spring environments in southern Taiwan. 61
22366362 2012
379
Corneal cross-linking as supplementary treatment option in melting keratitis: a case series. 61
22496015 2012
380
Hypoxia attenuates inflammatory mediators production induced by Acanthamoeba via Toll-like receptor 4 signaling in human corneal epithelial cells. 61
22450324 2012
381
Acanthamoeba keratitis in South India: a longitudinal analysis of epidemics. 61
22364672 2012
382
Treatment of early Acanthamoeba keratitis with alcohol-assisted epithelial debridement. 61
22236786 2012
383
Visual outcome in Japanese patients with Acanthamoeba keratitis. 61
22241017 2012
384
Evaluation of in vitro efficacy of combined riboflavin and ultraviolet a for Acanthamoeba isolates. 61
21992713 2012
385
Efficacy of miltefosine for topical treatment of Acanthamoeba keratitis in Syrian hamsters. 61
21748351 2012
386
Increase in acanthamoeba keratitis may be associated with use of multipurpose contact lens solution. 61
22354591 2012
387
Contact lens-related microbial keratitis: how have epidemiology and genetics helped us with pathogenesis and prophylaxis. 61
22134592 2012
388
Variable expression of human Beta defensins 3 and 9 at the human ocular surface in infectious keratitis. 61
22232436 2012
389
Microsporidia and Acanthamoeba: the role of emerging corneal pathogens. 61
22173072 2012
390
[Photodynamic therapy for infectious keratitis]. 61
22350551 2012
391
Bowman's layer encystment in cases of persistent Acanthamoeba keratitis. 61
22927735 2012
392
Advances in the diagnosis and treatment of acanthamoeba keratitis. 61
23304449 2012
393
A case of radial keratoneuritis in non-Acanthamoeba keratitis. 61
23055675 2012
394
Cytopathic effect of Acanthamoeba on human corneal fibroblasts. 61
22933834 2012
395
Corneal nerve alterations in acute Acanthamoeba and fungal keratitis: an in vivo confocal microscopy study. 61
22079969 2012
396
Recurrent interface abscess secondary to Acanthamoeba keratitis treated by deep anterior lamellar keratoplasty. 61
23275916 2012
397
New approach to diagnosis and treatment of Acanthamoeba keratitis--systematic review of literature. 61
23461162 2012
398
Various confocal scan features of cysts and trophozoites in cases with Acanthamoeba keratitis. 61
22427148 2012
399
Ex vivo laser confocal microscopy findings of cultured Acanthamoeba trophozoites. 61
22973090 2012
400
Assessing efficacy of combined riboflavin and UV-A light (365 nm) treatment of Acanthamoeba trophozoites. 61
22058341 2011
401
Practice patterns and opinions in the treatment of acanthamoeba keratitis. 61
21993459 2011
402
A case of sympathetic ophthalmia after a severe acanthamoeba keratitis. 61
21471815 2011
403
[Early stage of Acanthamoeba keratitis]. 61
22094218 2011
404
Utility of real-time polymerase chain reaction in diagnosing and treating acanthamoeba keratitis. 61
21955634 2011
405
Amoebicidal activity and chemical composition of Pterocaulon polystachyum (Asteraceae) essential oil. 61
21523423 2011
406
[Factors which affect the progression and severity of Acanthamoeba keratitis]. 61
22117322 2011
407
Double-biguanide therapy for resistant acanthamoeba keratitis. 61
22174703 2011
408
Microbiological cure times in acanthamoeba keratitis. 61
21637300 2011
409
Genotyping of Acanthamoeba isolated from water in recreational areas of Tehran, Iran. 61
21976207 2011
410
Lens epithelial cell death secondary to acanthamoeba keratitis: absence of capsular bag opacification six years after cataract surgery. 61
22220159 2011
411
Radial keratoneuritis as a presenting sign in acanthamoeba keratitis. 61
21887085 2011
412
Inflammation and the nervous system: the connection in the cornea in patients with infectious keratitis. 61
21460259 2011
413
Weak cytotoxic activity of miltefosine against clinical isolates of Acanthamoeba spp. 61
21506779 2011
414
Ultraviolet-a light and riboflavin therapy for acanthamoeba keratitis: a case report. 61
21941509 2011
415
[New diagnostic update in Acanthamoeba keratitis]. 61
21627900 2011
416
Acanthamoeba keratitis due to genotype T11 in a rigid gas permeable contact lens wearer in Spain. 61
21130679 2011
417
Serine-like proteolytic enzymes correlated with differential pathogenicity in patients with acute Acanthamoeba keratitis. 61
20456457 2011
418
Clinical outcomes and prognostic factors associated with acanthamoeba keratitis. 61
21045665 2011
419
[Acanthamoeba keratitis]. 61
21374536 2011
420
In vitro interactions of Fusarium and Acanthamoeba with drying residues of multipurpose contact lens solutions. 61
21071741 2011
421
In vitro amoebicidal activity of a ceragenin, cationic steroid antibiotic-13, against Acanthamoeba castellanii and its cytotoxic potential. 61
21142940 2011
422
Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases. 61
20884060 2011
423
Recurrent corneal ulceration in presence of synthetic microfibrils. 61
21750618 2011
424
Propylene glycol and contact-lens solutions containing this diol induce pseudocyst formation in acanthamoebae. 61
20728440 2011
425
Acanthamoeba keratitis--a diagnostic challenge. 61
22288216 2011
426
Microbial keratitis in Gujarat, Western India: findings from 200 cases. 61
22384294 2011
427
Toll-like receptor 4 signalling pathway activation in a rat model of Acanthamoeba Keratitis. 61
21155840 2011
428
Role of confocal microscopy in the diagnosis of fungal and acanthamoeba keratitis. 61
20801515 2011
429
Fluorescence amplified fragment length polymorphism for subtyping of genotypes of Acanthamoeba isolated from patients with keratitis. 61
21321424 2011
430
Pseudodendritic fungal epithelial keratitis in an extended wear contact lens user. 61
20864894 2011
431
Amebic meningoencephalitides and keratitis: challenges in diagnosis and treatment. 61
20802332 2010
432
[Trailing the footpath of Acanthamoeba keratitis]. 61
21268814 2010
433
[Characteristic appearance of early-stage Acanthamoeba keratitis]. 61
21268818 2010
434
Recent outbreaks of atypical contact lens-related keratitis: what have we learned? 61
21036209 2010
435
Antimicrobial peptides expression by ocular surface cells in response to Acanthamoeba castellanii: an in vitro study. 61
20679078 2010
436
Isolation and genotyping of Acanthamoeba strains from corneal infections in Italy. 61
20705732 2010
437
[Advances in basic and clinical corneal research]. 61
21176607 2010
438
Genotypic characterization of Acanthamoeba spp. causing ocular infections in Swedish patients: identification of the T15 genotype in a case of protracted keratitis. 61
20524785 2010
439
A retrospective study of nine cases of Acanthamoeba keratitis. 61
21060670 2010
440
Four cases of Acanthamoeba keratitis treated with phototherapeutic keratectomy. 61
20595894 2010
441
Current state of in vivo confocal microscopy in management of microbial keratitis. 61
21090995 2010
442
The clinical experience of Acanthamoeba keratitis at a tertiary care eye hospital. 61
20539211 2010
443
Clinical experience with Acanthamoeba keratitis at the cole eye institute, 1999-2008. 61
20539213 2010
444
Successful treatment of chronic stromal acanthamoeba keratitis with oral voriconazole monotherapy. 61
20539217 2010
445
Penetrating keratoplasty in active Acanthamoeba keratitis. 61
20520535 2010
446
First report of a mixed infection due to Acanthamoeba genotype T3 and Vahlkampfia in a cosmetic soft contact lens wearer in Iran. 61
19857491 2010
447
Acanthamoeba spp. in domestic tap water in houses of contact lens wearers in the metropolitan area of Mexico City. 61
19995560 2010
448
Isolation and identification of Acanthamoeba from Taiwan spring recreation areas using culture enrichment combined with PCR. 61
20434423 2010
449
Acanthamoeba spp.: efficacy of Bioclen FR One Step, a povidone-iodine based system for the disinfection of contact lenses. 61
20109451 2010
450
Acanthamoeba castellanii: in vitro effects of selected biological, physical and chemical factors. 61
20138870 2010
451
Nonpreserved amniotic membrane transplantation for bilateral toxic keratopathy caused by topical anesthetic abuse: a case report. 61
20698973 2010
452
In vivo and in vitro laser confocal microscopy to diagnose acanthamoeba keratitis. 61
20508505 2010
453
Diagnostic accuracy of microbial keratitis with in vivo scanning laser confocal microscopy. 61
20538659 2010
454
Therapeutic keratoplasty for microbial keratitis. 61
20531191 2010
455
Genotyping of Acanthamoeba isolates from corneal scrapings and contact lens cases of Acanthamoeba keratitis patients in Osaka, Japan. 61
20657076 2010
456
TLR4: the receptor bridging Acanthamoeba challenge and intracellular inflammatory responses in human corneal cell lines. 61
20125114 2010
457
Comparison of Pouzolzia indica methanolic extract and Virkon against cysts of Acanthamoeba spp. 61
21073052 2010
458
Bilateral acanthamoeba keratitis after orthokeratology. 61
19770731 2010
459
[Acanthamoeba keratitis in patients with contact lens wear in the Department of Ophthalmology in Debrecen]. 61
19756644 2010
460
[In vivo confocal microscopy: a new tool for the diagnosis of Acanthamoeba keratitis]. 61
20452092 2010
461
Bilateral Acanthamoeba keratitis in Synergeyes contact lens wear: clinical and confocal microscopy findings. 61
20386314 2010
462
Drug-resistant severe Acanthamoeba keratitis caused by rare T5 Acanthamoeba genotype. 61
20461886 2010
463
[Morphological characteristics in corneal smear of acanthamoeba keratitis]. 61
20654218 2010
464
Acanthamoeba endophthalmitis following penetrating keratoplasty for Acanthamoeba keratitis. 61
20385954 2010
465
Genotyping of Acanthamoeba isolates and clinical characteristics of patients with Acanthamoeba keratitis in China. 61
20056772 2010
466
Pathogenesis of acanthamoeba keratitis. 61
20427010 2010
467
Morphological, physiological and molecular biological characterisation of isolates from first cases of Acanthamoeba keratitis in Slovakia. 61
20127114 2010
468
Molecular Identification and Sequencing of Mannose Binding Protein (MBP) Gene of Acanthamoeba palestinensis. 61
22347229 2010
469
Detection of bacterial endosymbionts in clinical acanthamoeba isolates. 61
20031220 2010
470
Two cases of acanthamoeba keratitis diagnosed only by real-time polymerase chain reaction. 61
19770722 2010
471
[Acanthamoeba keratitis. Report of 3 cases diagnosed in central Tunisia]. 61
20415171 2010
472
Treatment with voriconazole in 3 eyes with resistant Acanthamoeba keratitis. 61
19875089 2010
473
Shifting distribution of Chicago-area Acanthamoeba keratitis cases. 61
20065234 2010
474
[Amoebas of the genus acanthamoeba as an etiological factor of keratitis]. 61
20825074 2010
475
Evaluation of three different methods to establish animal models of Acanthamoeba keratitis. 61
20046525 2010
476
Resurgence of Acanthamoeba keratitis in Auckland, New Zealand: a 7-year review of presentation and outcomes. 61
20447096 2010
477
Diverse challenges in pediatric compounding: treating pulmonary hypertension, uncombable hair syndrome, and acanthamoeba keratitis. 61
23965369 2010
478
Multipurpose disinfecting solution and Acanthamoeba keratitis. 61
19907288 2010
479
Acanthamoeba keratitis with Curvularia co-infection. 61
20061771 2010
480
Rapid diagnosis of Acanthamoeba keratitis. 61
19939792 2009
481
Ring keratitis associated with topical abuse of a dilute anesthetic after refractive surgery. 61
20040463 2009
482
Analysis of the risk factors predisposing to fungal, bacterial & Acanthamoeba keratitis in south India. 61
20090138 2009
483
Culture Negative Confoscan Positive Acanthamoeba Keratitis: A relentless course. 61
21509321 2009
484
Pythium insidiosum keratitis in contact lens wear: a case report. 61
19730096 2009
485
Rapid detection of Acanthamoeba cysts in frozen sections of corneal scrapings with Fungiflora Y. 61
19939794 2009
486
Pouzolzia indica methanolic extract fraction 2 and povidone-iodine induced changes in the cyst of Acanthamoeba spp.: light and electron microscopic studies. 61
19938742 2009
487
A case of descemet's membrane rupture in a patient affected by Acanthamoeba Keratitis. 61
19726997 2009
488
Perioperative treatment and prognostic factors for penetrating keratoplasty in Acanthamoeba keratitis unresponsive to medical treatment. 61
19424711 2009
489
Contact lens-related acanthamoeba keratitis. 61
19741556 2009
490
[Diagnosing of Acanthamoeba keratitis]. 61
20052817 2009
491
Acanthamoeba keratitis: diagnosis and treatment update 2009. 61
19660733 2009
492
Epidemiological characteristics, predisposing factors and microbiological profiles of infectious corneal ulcers: the Portsmouth corneal ulcer study. 61
19502241 2009
493
Anti-acanthamoeba efficacy and toxicity of miltefosine in an organotypic skin equivalent. 61
19549672 2009
494
In vivo confocal microscopy in the diagnosis and management of acanthamoeba keratitis showing new cystic forms. 61
19788672 2009
495
Painless Acanthamoeba keratitis in a soft contact lens wearer--case report. 61
19860131 2009
496
Three cases of Acanthamoeba keratitis diagnosed and treated in the early stage. 61
19763030 2009
497
National outbreak of Acanthamoeba keratitis associated with use of a contact lens solution, United States. 61
19751585 2009
498
New tool for the simultaneous detection of 10 different genotypes of Acanthamoeba available from the American Type Culture Collection. 61
19403520 2009
499
Resistance of Acanthamoeba cysts to disinfection in multiple contact lens solutions. 61
19403771 2009
500
Review of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: experience of over a decade. 61
19574694 2009
501
Genotypic identification of Acanthamoeba sp. isolates associated with an outbreak of acanthamoeba keratitis. 61
19512903 2009
502
Acanthamoeba keratitis associated with contact lens wear in Singapore. 61
19403109 2009
503
Polymicrobial keratitis: Acanthamoeba and infectious crystalline keratopathy. 61
19327742 2009
504
Twenty years of acanthamoeba keratitis. 61
19421047 2009
505
[Recurrent acanthamoeba keratitis in the corneal graft]. 61
19507104 2009
506
Cosmetic contact lens-related Acanthamoeba keratitis. 61
19594573 2009
507
Keratoplasty for treatment of Acanthamoeba keratitis. 61
19410943 2009
508
Molecular identification of t4 and t5 genotypes in isolates from acanthamoeba keratitis patients. 61
19321730 2009
509
An atypical case of microcysts associated with silicone hydrogel contact lens: findings on in vivo confocal laser microscopy. 61
19421023 2009
510
Isolation and genotyping of potentially pathogenic Acanthamoeba strains from dust sources in Iran. 61
19185896 2009
511
Acanthamoeba keratitis with perforation after corneal crosslinking and bandage contact lens use. 61
19304108 2009
512
Bilateral acanthamoeba keratitis after orthokeratology. 61
19387241 2009
513
Acanthamoeba keratitis cluster: an increase in Acanthamoeba keratitis in Australia. 61
19723126 2009
514
Acanthamoeba keratitis: a comprehensive photographic reference of common and uncommon signs. 61
19723132 2009
515
The plague that won't simply go away: acanthamoeba keratitis. 61
19426402 2009
516
Medical treatment for combined Fusarium and Acanthamoeba keratitis. 61
18507727 2009
517
Successful treatment of Acanthamoeba keratitis without anti-amoebic agents. 61
19271053 2009
518
MoisturePlus contact lens solution as a source of acanthamoeba keratitis. 61
19158570 2009
519
Acanthamoeba sclerokeratitis. 61
18843498 2009
520
Unusual case of methicillin resistant staphylococcus aureus and acanthamoeba keratitis in a non-contact lens wearer from Kashmir, India. 61
21686708 2009
521
Amoebicidal activities of alexidine against 3 pathogenic strains of acanthamoeba. 61
19125040 2009
522
An atypical presentation of acanthamoeba keratitis in a patient with keratoconus treated briefly with topical anesthetic. 61
19125047 2009
523
Temporal and seasonal trends in Acanthamoeba keratitis. 61
19092396 2009
524
[Case report: Acanthamoeba keratitis]. 61
20101578 2009
525
[Ultrastructure study of pathogen of acanthamoeba keratitis]. 61
19176099 2008
526
Contact lens-related acanthamoeba keratitis in a patient with chronic fatigue syndrome. 61
18997544 2008
527
Acanthamoeba keratitis associated with cosmetic contact lens wear. 61
19098954 2008
528
Prognostic factors affecting visual outcome in Acanthamoeba keratitis. 61
18571729 2008
529
The potential pathogenicity of chlorhexidine-sensitive Acanthamoeba strains isolated from contact lens cases from asymptomatic individuals in Tenerife, Canary Islands, Spain. 61
18927419 2008
530
Validation of real-time PCR for laboratory diagnosis of Acanthamoeba keratitis. 61
18701667 2008
531
Acanthamoeba keratitis presenting as a plaque. 61
18812773 2008
532
Acanthamoeba keratitis--importance of the early diagnosis. 61
19138028 2008
533
[Acanthamoeba keratitis: diagnosis to consider]. 61
19810616 2008
534
[Acanthamoeba keratitis]. 61
18926962 2008
535
Corneal graft survival after therapeutic keratoplasty for Acanthamoeba keratitis. 61
18752517 2008
536
Acanthamoeba: a review of its potential to cause keratitis, current lens care solution disinfection standards and methodologies, and strategies to reduce patient risk. 61
18779663 2008
537
The genotypic characterisation of Acanthamoeba isolates from human ocular samples. 61
18586902 2008
538
The relative value of confocal microscopy and superficial corneal scrapings in the diagnosis of Acanthamoeba keratitis. 61
18650660 2008
539
Contact lens-related microbial keratitis: recent outbreaks. 61
18545011 2008
540
Blindness due to Acanthamoeba: first case report from Sudan. 61
21475499 2008
541
Detection of acanthamoeba in tap water and contact lens cases using polymerase chain reaction. 61
18594344 2008
542
Efficacy of contact lens systems against recent clinical and tap water Acanthamoeba isolates. 61
18580265 2008
543
Bilateral Acanthamoeba ulcer in a user of disposable soft contact lenses: a tragic incident or a consequence of the aggressive policy of soft contact lens trading? 61
18641837 2008
544
Encystment of Acanthamoeba during incubation in multipurpose contact lens disinfectant solutions and experimental formulations. 61
18463477 2008
545
Long-term use of topical tacrolimus (FK506) in high-risk penetrating keratoplasty. 61
18434855 2008
546
In vivo and ex vivo laser confocal microscopy findings in patients with early-stage acanthamoeba keratitis. 61
18434848 2008
547
Rapidly progressive cataract and iris atrophy during treatment of Acanthamoeba keratitis. 61
18452764 2008
548
Fusarium and Acanthamoeba keratitis: can a single centre detect outbreaks? 61
18441185 2008
549
Predisposing factors and etiologic diagnosis of ulcerative keratitis. 61
18362653 2008
550
Role of human tear fluid in Acanthamoeba interactions with the human corneal epithelial cells. 61
17931971 2008
551
Identification of Acanthamoeba genotype T4 and Paravahlkampfia sp. from two clinical samples. 61
18287307 2008
552
Milk components inhibit Acanthamoeba-induced cytopathic effect. 61
18326724 2008
553
Clinical and experimental findings in Acanthamoeba keratitis with Heidelberg Retina Tomograph III-RCM. 61
18339048 2008
554
Acanthamoeba keratitis: persistent organisms without inflammation after 1 year of topical chlorhexidine. 61
18216589 2008
555
Bilateral acanthamoeba keratitis. 61
18222188 2008
556
Cytotoxic activity of N-chlorotaurine on Acanthamoeba spp. 61
18039920 2008
557
Impaired innate immunity of ocular surface is the key bridge between extended contact lens wearing and occurrence of Acanthamoeba keratitis. 61
17689022 2008
558
Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis. 61
17996208 2008
559
Effect of immunization with the mannose-induced Acanthamoeba protein and Acanthamoeba plasminogen activator in mitigating Acanthamoeba keratitis. 61
18055809 2007
560
Synthesis, antimicrobial and antineoplastic activities for agelasine and agelasimine analogs with a beta-cyclocitral derived substituent. 61
17994607 2007
561
In vitro effectiveness of Thymus sipyleus subsp. sipyleus var. sipyleus on Acanthamoeba castellanii and its cytotoxic potential on corneal cells. 61
17661186 2007
562
Good visual outcome after prompt treatment of acanthamoeba keratitis associated with overnight orthokeratology lens wear. 61
17993830 2007
563
Clinical and histologic evaluations of experimental Acanthamoeba keratitis. 61
17701053 2007
564
The effect of propolis in experimental Acanthamoeba keratitis. 61
17997780 2007
565
Acanthamoeba keratitis and contact lens wear: static or increasing problem? 61
17975435 2007
566
Acanthamoeba keratitis related to cosmetic contact lenses. 61
17997788 2007
567
Trends in microbial keratitis associated with orthokeratology. 61
17975424 2007
568
Role of activated macrophages in Acanthamoeba keratitis. 61
18163346 2007
569
Acanthamoeba keratitis. 61
18049367 2007
570
Acanthamoeba keratitis and contact lens wear. 61
17697181 2007
571
Deep lamellar keratoplasty for acanthamoeba keratitis. 61
17721312 2007
572
Acanthamoeba keratitis: 2007: a train wreck in slow motion. 61
17873621 2007
573
Efficacy of contact lens storage solutions against trophozoite and cyst of Acanthamoeba castellanii strain 1BU and their cytotoxic potential on corneal cells. 61
17514482 2007
574
Parasites on the rise: a new epidemic of Acanthamoeba keratitis. 61
17659960 2007
575
The association of contact lens solution use and Acanthamoeba keratitis. 61
17588524 2007
576
Sensitivity and specificity of confocal scan in the diagnosis of infectious keratitis. 61
17667609 2007
577
Surgical therapies for Acanthamoeba keratitis by phototherapeutic keratectomy and deep lamellar keratoplasty. 61
17667628 2007
578
Bilateral Acanthamoeba keratitis in an experienced two-weekly disposable contact lens wearer. 61
17630630 2007
579
The application of in vivo confocal scanning laser microscopy in the management of Acanthamoeba keratitis. 61
17679934 2007
580
Acanthamoeba keratitis: a parasite on the rise. 61
17592320 2007
581
Acanthamoeba keratitis: an overview. 61
17953323 2007
582
Acanthamoeba keratitis multiple states, 2005-2007. 61
17538529 2007
583
The clinical diagnosis of microbial keratitis. 61
17408586 2007
584
Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea. 61
17428307 2007
585
Comparison of a novel semi-nested polymerase chain reaction (PCR) with a uniplex PCR for the detection of Acanthamoeba genome in corneal scrapings. 61
17268807 2007
586
Severe acanthamoeba keratitis after overnight orthokeratology. 61
17502745 2007
587
[Painless acanthamoeba keratitis]. 61
17318475 2007
588
Elliptical nonmechanical corneal trephination: intraoperative complications and long-term outcome of 42 consecutive excimer laser penetrating keratoplasties. 61
17457188 2007
589
Cellulose biosynthesis pathway is a potential target in the improved treatment of Acanthamoeba keratitis. 61
17225099 2007
590
[How to prescribe local antifungal and antiamoebicide topical drugs]. 61
17486041 2007
591
Comparison of PCR, microscopic examination and culture for the early diagnosis and characterization of Acanthamoeba isolates from ocular infections. 61
17393203 2007
592
[Diagnosis of Acanthamoeba corneal infection by impression cytology: case report]. 61
17589711 2007
593
Microbial keratitis in South India: influence of risk factors, climate, and geographical variation. 61
17464852 2007
594
Factors affecting the epidemiology of Acanthamoeba keratitis. 61
17464851 2007
595
Acanthamoeba keratitis related to orthokeratology. 61
17377749 2007
596
Acanthamoeba keratitis. 61
17270694 2007
597
[Acanthamoeba keratitis: about the first two Tunisian cases]. 61
17402694 2007
598
Severe reactive ischemic posterior segment inflammation in acanthamoeba keratitis: a new potentially blinding syndrome. 61
17123611 2007
599
Combined fungal and acanthamoeba keratitis: diagnosis by in vivo confocal microscopy. 61
16858439 2007
600
Acanthamoeba keratitis due to Acanthamoeba genotype T4 in a non-contact-lens wearer in Turkey. 61
17013653 2007
601
A study of the spectrum of Acanthamoeba keratitis: a three-year study at a tertiary eye care referral center in South India. 61
17189885 2007
602
Acanthamoeba keratitis. 61
17450005 2007
603
Updates in Acanthamoeba keratitis. 61
17224672 2007
604
Acanthamoeba keratitis. 61
17157149 2006
605
Acanthamoeba keratitis associated with misuse of daily disposable contact lenses. 61
16945570 2006
606
Molecular characterization of Acanthamoeba isolated from amebic keratitis related to orthokeratology lens overnight wear. 61
17170573 2006
607
Oral immunization with Acanthamoeba castellanii mannose-binding protein ameliorates amoebic keratitis. 61
16982837 2006
608
Gemella haemolysans infectious crystalline keratopathy. 61
17172910 2006
609
Intracorneal instillation of latex beads induces macrophage-dependent protection against Acanthamoeba keratitis. 61
17065507 2006
610
Effects of topical anaesthetics and fluorescein on the real-time PCR used for the diagnosis of Herpesviruses and Acanthamoeba keratitis. 61
16899529 2006
611
[Diagnosis of Acanthamoeba spp. keratitis with PCR]. 61
17114997 2006
612
[Keratitis due to Acanthamoeba]. 61
17125668 2006
613
Dacryoadenitis associated with Acanthamoeba keratitis. 61
16966617 2006
614
Acanthamoeba keratitis in a U.S. Army soldier after unauthorized use of contact lenses in the combat theater. 61
17036601 2006
615
[Infections caused by free-living amebas. Historical commentaries, taxonomy and nomenclature, protozoology and clinicopathologic features]. 61
16896492 2006
616
Detection of a serine proteinase gene in Acanthamoeba genotype T6 (Amoebozoa: Lobosea). 61
16545805 2006
617
Corneal reshaping: is it a good alternative to refractive surgery? 61
16900034 2006
618
Diagnosis and management of Acanthamoeba keratitis. 61
16900022 2006
619
Epidemiological characteristics of a Chicago-area Acanthamoeba keratitis outbreak. 61
16876498 2006
620
Unusual case of acanthamoeba keratitis in a contact lens wearer. 61
16845260 2006
621
Secondary glaucoma associated with advanced acanthamoeba keratitis. 61
16845263 2006
622
Acanthamoeba keratitis after LASIK. 61
16805128 2006
623
[Anti-infective drug therapy in ophthalmology--part 4: acanthamoeba keratitis]. 61
16804818 2006
624
Use of higher medication concentrations in the treatment of acanthamoeba keratitis. 61
16769857 2006
625
Acanthamoeba keratitis in a 5-year-old boy without a history of contact lens usage. 61
16633040 2006
626
The pathophysiology of Acanthamoeba keratitis. 61
16500148 2006
627
The immunobiology of Acanthamoeba keratitis. 61
16697233 2006
628
Tandem scanning confocal corneal microscopy in the diagnosis of suspected acanthamoeba keratitis. 61
16581415 2006
629
[Therapeutic penetrating keratoplasty for microbial keratitis]. 61
16599315 2006
630
Acanthamoeba keratitis: clinical characteristics and management. 61
16427699 2006
631
Bilateral acanthamoeba keratitis and treatment strategy based on lesion depth. 61
16462876 2006
632
Acanthamoeba keratitis and contact lens disinfecting solutions. 61
16785754 2006
633
Microbial keratitis predisposing factors and morbidity. 61
16360210 2006
634
A case of acanthamoeba keratitis as a result of a cosmetic contact lens. 61
16415692 2006
635
One- and two-step hydrogen peroxide contact lens disinfection solutions against Acanthamoeba: how effective are they? 61
15543174 2005
636
Results of penetrating keratoplasty for visual rehabilitation after Acanthamoeba keratitis. 61
16376655 2005
637
Heidelberg retina tomograph II findings of Acanthamoeba keratitis. 61
16321898 2005
638
Acanthamoeba keratitis during orthokeratology. 61
16160506 2005
639
[Non-viral infectious keratitis: predisposing factors, etiologic agents and laboratory diagnosis]. 61
16502645 2005
640
Granulomatous inflammation in Acanthamoeba keratitis: an immunohistochemical study of five cases and review of literature. 61
16327118 2005
641
[A case of free-living Amoebae keratitis in a non contact lens wearer]. 61
16230291 2005
642
Acanthamoeba genotype T4 from the UK and Iran and isolation of the T2 genotype from clinical isolates. 61
16014429 2005
643
Failure of Acanthamoeba castellanii to produce intraocular infections. 61
15980238 2005
644
Acanthamoeba keratitis in Kashmir. 61
16761775 2005
645
Swimming with soft contact lenses: danger of acanthamoeba keratitis. 61
15919625 2005
646
The role of domestic tap water in Acanthamoeba contamination in contact lens storage cases in Korea. 61
15951638 2005
647
Amniotic membrane transplantation and fibrin glue in the management of corneal ulcers and perforations: a review of 33 cases. 61
15829790 2005
648
Identification and distribution of Acanthamoeba species genotypes associated with nonkeratitis infections. 61
15814986 2005
649
Persistent acanthamoeba keratitis in a non-contact lens wearer following exposure to bird seed dust. 61
15722327 2005
650
[Acanthamoeba keratitis]. 61
15898339 2005
651
Six-year review of Acanthamoeba keratitis in New South Wales, Australia: 1997-2002. 61
15670077 2005
652
Role of contact lens wear, bacterial flora, and mannose-induced pathogenic protease in the pathogenesis of amoebic keratitis. 61
15664950 2005
653
Development of colorimetric microtiter plate assay for assessment of antimicrobials against Acanthamoeba. 61
15695656 2005
654
Keratocyte loss in corneal infection through apoptosis: a histologic study of 59 cases. 61
15617577 2004
655
Local and systemic humoral immune response during acute and chronic Acanthamoeba keratitis in rabbits. 61
15764087 2004
656
A case of trauma related Acanthamoeba keratitis. 61
16493405 2004
657
[Clinical study of the treatment of acanthamoeba keratitis by penetrating keratoplasty]. 61
15634482 2004
658
Acanthamoeba keratitis in non-contact lens wearers in India: DNA typing-based validation and a simple detection assay. 61
15477452 2004
659
Diffusion of metronidazole released from aqueous solution and a gel through human and rabbit corneas. 61
15650517 2004
660
[Amniotic membrane transplantation for the treatment severe acanthamoeba keratitis]. 61
15559648 2004
661
Acanthamoeba keratitis - a six year epidemiological review from a tertiary care eye hospital in south India. 61
17642743 2004
662
Confocal microscopy in early diagnosis of Acanthamoeba keratitis. 61
15521280 2004
663
Delay in diagnosis and outcome of Acanthamoeba keratitis. 61
15221303 2004
664
Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animals. 61
15313128 2004
665
Results of therapeutic penetrating keratoplasty. 61
15295664 2004
666
In vitro transcorneal penetration of metronidazole and its potential use as adjunct therapy in Acanthamoeba keratitis. 61
15097135 2004
667
Laboratory investigation of Acanthamoeba lugdunensis from patients with keratitis. 61
15111597 2004
668
Laser in situ keratomileusis treatment for myopia after Acanthamoeba keratitis. 61
15260359 2004
669
Arthrographis keratitis mimicking acanthamoeba keratitis. 61
15084869 2004
670
Are cataract and iris atrophy toxic complications of medical treatment of acanthamoeba keratitis? 61
15043548 2004
671
Molecular and physiological evaluation of subtropical environmental isolates of Acanthamoeba spp., causal agent of Acanthamoeba keratitis. 61
15134255 2004
672
Characterisation and differentiation of pathogenic and non-pathogenic Acanthamoeba strains by their protein and antigen profiles. 61
14722757 2004
673
Opportunistic amoebae: challenges in prophylaxis and treatment. 61
15072770 2004
674
Impression cytology in the diagnosis of acanthamoeba keratitis with surface involvement. 61
14962424 2004
675
Confocal microscopy: a report by the American Academy of Ophthalmology. 61
15019397 2004
676
[Clinical forms of acanthamoeba keratitis as viewed from the standpoint of biomicroscopy and confocal microscopy]. 61
15017780 2004
677
Acanthamoeba keratitis: the role of domestic tap water contamination in the United Kingdom. 61
14691169 2004
678
Health effects of Acanthamoeba spp. and its potential for waterborne transmission. 61
14561077 2004
679
First cases of Acanthamoeba keratitis in Slovakia. 61
15627346 2004
680
Acanthamoeba keratitis as a complication of orthokeratology. 61
14644232 2003
681
A novel combination treatment of chlorhexidine gluconate, natamycin (pimaricin) and debridement for a Acanthamoeba keratitis. 61
14636856 2003
682
Acanthamoeba keratitis update-incidence, molecular epidemiology and new drugs for treatment. 61
14631394 2003
683
Pathogenic Acanthamoeba spp secrete a mannose-induced cytolytic protein that correlates with the ability to cause disease. 61
14573643 2003
684
Nummular infiltrates in Acanthamoeba keratitis. 61
14510809 2003
685
[Acanthamoeba keratitis after use of soft contact lenses--case report]. 61
14518364 2003
686
Evaluation of hematoxylin and eosin and special stains for the detection of acanthamoeba keratitis in penetrating keratoplasties. 61
12967807 2003
687
Present status of contact lens-induced corneal infections. 61
14564769 2003
688
Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity. 61
12917179 2003
689
Treatment of Acanthamoeba keratitis. 61
15482114 2003
690
Use of 18S rRNA gene-based PCR assay for diagnosis of acanthamoeba keratitis in non-contact lens wearers in India. 61
12843065 2003
691
Enhanced killing of Acanthamoeba cysts with a plant peroxidase-hydrogen peroxide-halide antimicrobial system. 61
12732522 2003
692
Non-contact lens related Acanthamoeba keratitis at a tertiary eye care center in south India: Implications for eye care programs in the region. 61
12709670 2003
693
Bilateral Acanthamoeba keratitis with late recurrence of the infection in a corneal graft: a case report. 61
12747654 2003
694
Acanthamoeba keratitis. 61
12642336 2003
695
Advantages of using mitochondrial 16S rDNA sequences to classify clinical isolates of Acanthamoeba. 61
12601042 2003
696
Acanthamoeba keratitis in a non-contact lens wearer with human immunodeficiency virus. 61
12751722 2003
697
An atypical presentation of Acanthamoeba keratitis in a noncontact lens wearer. 61
12769151 2003
698
Epidemiological typing of Acanthamoeba strains isolated from keratitis cases in Belgium. 61
12784575 2003
699
[Study on the effect of H2O2 against Acanthamoeba in vitro]. 61
14628372 2003
700
[Treatment of Acanthamoeba keratitis: possibilities, problems, and new approaches]. 61
15508774 2003
701
Trends in contact lens-associated microbial keratitis in Southern India. 61
12511359 2003
702
[Clinical management and prognosis in Acanthamoeba keratitis: a retrospective study of 25 cases]. 61
12527823 2002
703
[A clinico-pathological case report of necrotizing ulcerating keratopathy due to topical anaesthetic abuse]. 61
12430041 2002
704
Treatment of advanced acanthamoeba keratitis with deep lamellar keratectomy and conjunctival flap. 61
12352090 2002
705
Acanthamoeba keratitis in Ghana. 61
12234904 2002
706
Incidence and risk factors for microbial keratitis in Hong Kong: comparison with Europe and North America. 61
12194077 2002
707
Corneal complications following abuse of topical anesthetics. 61
12474918 2002
708
Molecular and physiological differentiation between pathogenic and nonpathogenic Acanthamoeba. 61
12177742 2002
709
Recent advances in the treatment of Acanthamoeba keratitis. 61
12145728 2002
710
Therapeutic keratoplasty for infectious keratitis: a review of the literature. 61
12144228 2002
711
Phagocytosis affects biguanide sensitivity of Acanthamoeba spp. 61
12069957 2002
712
Acanthamoeba sclerokeratitis: treatment with systemic immunosuppression. 61
12045063 2002
713
18S ribosomal DNA typing and tracking of Acanthamoeba species isolates from corneal scrape specimens, contact lenses, lens cases, and home water supplies of Acanthamoeba keratitis patients in Hong Kong. 61
11980931 2002
714
Acanthamoeba keratitis in England and Wales: incidence, outcome, and risk factors. 61
11973250 2002
715
[Acanthamoeba keratitis, a possible dibromo propamidine isethionate resistance]. 61
12023748 2002
716
[Acanthamoeba keratitis treated with propamidine and polyhexamethyl biguanide (PHMB)]. 61
12090104 2002
717
Acanthamoeba keratitis presenting as dendritic keratitis in a soft contact lens wearer. 61
12022742 2002
718
Progressive ulcerative keratitis related to the use of topical chlorhexidine gluconate (0.02%). 61
11862106 2002
719
Cytotoxic activities of alkylphosphocholines against clinical isolates of Acanthamoeba spp. 61
11850250 2002
720
Acanthamoeba keratitis after photorefractive keratectomy. 61
11821223 2002
721
Role of tear anti-acanthamoeba IgA in Acanthamoeba keratitis. 61
12614001 2002
722
The role of the innate and adaptive immune responses in Acanthamoeba keratitis. 61
11916309 2002
723
Chorioretinitis after keratitis caused by Acanthamoeba: case report and review of the literature. 61
11733264 2001
724
Pathogenicity, morphology, and differentiation of Acanthamoeba. 61
11685503 2001
725
[Orthokeratology induced infective corneal ulcer]. 61
11840754 2001
726
Effect of steroids on Acanthamoeba cysts and trophozoites. 61
11687533 2001
727
Atypical presentation of Acanthamoeba keratitis. 61
11588431 2001
728
Evaluation of immunoperoxidase staining technique in the diagnosis of Acanthamoeba keratitis. 61
15887727 2001
729
Tear IgA and serum IgG antibodies against Acanthamoeba in patients with Acanthamoeba keratitis. 61
11473164 2001
730
Anti-Acanthamoeba IgG, IgM, and IgA immunoreactivities in correlation to strain pathogenicity. 61
11511003 2001
731
[Painless acanthamoeba keratitis]. 61
11573159 2001
732
Microwave treatment of contact lens cases contaminated with acanthamoeba. 61
11413399 2001
733
Fungal ring infiltrates in disposable contact lens wearers. 61
11506444 2001
734
Genetic analyses of Acanthamoeba isolates from contact lens storage cases of students in Seoul, Korea. 61
11441503 2001
735
Acanthamoeba keratitis in Pondicherry. 61
12170932 2001
736
Use of subgenic 18S ribosomal DNA PCR and sequencing for genus and genotype identification of acanthamoebae from humans with keratitis and from sewage sludge. 61
11326011 2001
737
Exacerbation of Acanthamoeba keratitis in animals treated with anti-macrophage inflammatory protein 2 or antineutrophil antibodies. 61
11292716 2001
738
Acanthamoeba keratitis associated with fungal keratitis. 61
11292419 2001
739
Persistence of acanthamoeba antigen following acanthamoeba keratitis. 61
11222330 2001
740
A comparison of cyst age and assay method of the efficacy of contact lens disinfectants against Acanthamoeba. 61
11222342 2001
741
Immunological inter-strain crossreactivity correlated to 18S rDNA sequence types in Acanthamoeba spp. 61
11239936 2001
742
Coexistent adenoviral keratoconjunctivitis and Acanthamoeba keratitis. 61
11202467 2000
743
Keratocyte loss in Acanthamoeba keratitis: phagocytosis, necrosis or apoptosis? 61
11340887 2000
744
A case series of acanthamoeba keratitis in Singapore. 61
11284615 2000
745
[Three cases of bilateral Acanthamoeba keratitis]. 61
11081312 2000
746
Correlations between morphological, molecular biological, and physiological characteristics in clinical and nonclinical isolates of Acanthamoeba spp. 61
11010891 2000
747
Patient characteristics, diagnosis, and treatment of non-contact lens related Acanthamoeba keratitis. 61
11004092 2000
748
Advances in the management of keratomycosis and Acanthamoeba keratitis. 61
11009320 2000
749
Proteases as markers for differentiation of pathogenic and nonpathogenic species of Acanthamoeba. 61
10921939 2000
750
Acanthamoeba keratitis occurring with daily disposable contact lens wear. 61
10873999 2000
751
The reculture technique: individualizing the treatment of Acanthamoeba keratitis. 61
10928758 2000
752
Therapy of acanthamoeba keratitis--an experimental study. 61
10941629 2000
753
[Clinical aspects and therapy of acanthamoeba keratitis]. 61
10916392 2000
754
Topical ocular anesthetic abuse: case report. 61
10958042 2000
755
[Pain and corneal pathology]. 61
10794991 2000
756
Antimicrobial susceptibility of 19 Australian corneal isolates of Acanthamoeba. 61
10933775 2000
757
Methods used to evaluate the effectiveness of contact lens care solutions and other compounds against Acanthamoeba: a review of the literature. 61
10810937 2000
758
Laser in situ Keratomileusis Following Acanthamoeba Keratitis. 61
24364509 2000
759
Confirmation of confocal microscopy diagnosis of Acanthamoeba keratitis using polymerase chain reaction analysis. 61
10676782 2000
760
The diagnosis and management of Acanthamoeba keratitis. 61
10656311 2000
761
[Report of a case of Acanthamoeba keratitis]. 61
10853307 2000
762
[Laboratory diagnosis of Acanthamoeba keratitis]. 61
12567643 2000
763
[Acanthamoeba keratitis: search for a healthy carrier in Mali]. 61
10989790 2000
764
[Acanthamoeba keratitis and its diagnosis, treatment and prevention]. 61
12567645 2000
765
Acanthamoeba strains isolated from organs of freshwater fishes. 61
10647044 1999
766
Treatment of Acanthamoeba keratitis combined with fungal infection with polyhexamethylene biguanide. 61
10630064 1999
767
Acanthamoeba keratitis occurring with daily disposable contact lens wear. 61
10636683 1999
768
Acanthamoeba keratitis following optical keratoplasty. 61
10692939 1999
769
Fluorescent oligonucleotide probes for clinical and environmental detection of Acanthamoeba and the T4 18S rRNA gene sequence type. 61
10405422 1999
770
Monoclonal IgA antibodies protect against Acanthamoeba keratitis. 61
10375451 1999
771
Acanthamoeba keratitis with live isolates treated with cryosurgery and fluconazole. 61
10372884 1999
772
Severe Acanthamoeba sclerokeratitis in a non-contact lens wearer. 61
10406160 1999
773
Results of a trial of combined propamidine isethionate and neomycin therapy for Acanthamoeba keratitis. Brolene Study Group. 61
10328395 1999
774
Utility of Fungiflora Y stain in rapid diagnosis of Acanthamoeba keratitis. 61
10917688 1999
775
The pathogenesis of Acanthamoeba keratitis. 61
10602676 1999
776
Treatment of acanthamoeba keratitis with chlorhexidine. 61
10201605 1999
777
Complacency regarding the risks of Acanthamoeba keratitis. 61
16303402 1999
778
The immunobiology of Acanthamoeba keratitis. 61
10457588 1999
779
Acanthamoeba keratitis: a review. 61
10670164 1999
780
[Acanthamoeba keratitis]. 61
10337823 1999
781
Acanthamoeba keratitis in Scotland: risk factors for contact lens wearers. 61
16303407 1999
782
[Establishment of a rabbit model of Acanthamoeba keratitis]. 61
12563867 1999
783
Population-based cohort study of microbial keratitis in Scotland: incidence and features. 61
16303406 1999
784
Adherence of Acanthamoeba to human corneal epithelial cells recovered from normal non-lens wearers and asymptomatic contact lens wearers. 61
16303415 1999
785
In vivo tandem scanning confocal microscopy in acanthamoeba keratitis. 61
10188372 1998
786
Role of mucosal IgA in the resistance to Acanthamoeba keratitis. 61
9856776 1998
787
Acanthamoeba keratitis: multicentre survey in England 1992-6. National Acanthamoeba Keratitis Study Group. 61
9930269 1998
788
Non-Acanthamoeba amebic keratitis. 61
9820951 1998
789
Impact of oral immunization with Acanthamoeba antigens on parasite adhesion and corneal infection. 61
9804142 1998
790
Laboratory diagnosis of Acanthamoeba keratitis using buffered charcoal-yeast extract agar. 61
9780107 1998
791
Acanthamoebiasis in Korea: two new cases with clinical cases review. 61
9821799 1998
792
Acanthamoeba adherence to contact lenses, removal by rinsing procedures, and survival to some ophthalmic products. 61
10376283 1998
793
In vitro effectiveness of povidone-iodine on Acanthamoeba isolates from human cornea. 61
9736540 1998
794
Confirmatory evidence from 18S rRNA gene analysis for in vivo development of propamidine resistance in a temporal series of Acanthamoeba ocular isolates from a patient. 61
9687426 1998
795
Acanthamoeba keratitis in New Zealand, including two cases with in vivo resistance to polyhexamethylene biguanide. 61
9717755 1998
796
An epidemic of presumed Acanthamoeba keratitis that followed regional flooding. Results of a case-control investigation. 61
9715690 1998
797
Binding of Acanthamoeba to [corrected] mannose-glycoproteins of corneal epithelium: effect of injury. 61
9723990 1998
798
Ophthaproblem. Contact lens (Acanthamoeba) keratitis. 61
9721412 1998
799
Role of carbohydrate-mediated adherence in cytopathogenic mechanisms of Acanthamoeba. 61
9624184 1998
800
Polymerase chain reaction analysis of corneal epithelial and tear samples in the diagnosis of Acanthamoeba keratitis. 61
9620088 1998
801
Acanthamoeba keratitis. 61
9635900 1998
802
Acanthamoeba keratitis with symbiosis of Hartmannella ameba. 61
9625566 1998
803
Is polyhexamethylene biguanide alone effective for Acanthamoeba keratitis? 61
9603394 1998
804
Acridine orange staining for rapid diagnosis of Acanthamoeba keratitis. 61
9587842 1998
805
An immortalized hamster corneal epithelial cell line for studies of the pathogenesis of Acanthamoeba keratitis. 61
9543629 1998
806
Early diagnosis of mycotic keratitis: predictive value of potassium hydroxide preparation. 61
9707845 1998
807
Polyhexamethylene biguanide treatment for Acanthamoeba keratitis. 61
9524039 1998
808
[Acanthamoeba keratitis]. 61
9768024 1998
809
Treatment of Acanthamoeba keratitis. 61
9436874 1998
810
The epidemic of Acanthamoeba keratitis: where do we stand? 61
9436873 1998
811
Acanthamoeba keratitis: increased sensitivity of the detection of parasites by modified cultivation procedure. 61
10225407 1998
812
Has the introduction of multi-purpose solutions contributed to a reduced incidence of Acanthamoeba keratitis in contact lens wearers? A review. 61
16303384 1998
813
Restriction enzyme analysis of mitochondrial DNA of Acanthamoeba strains isolated from corneal lesions. 61
9507361 1998
814
Mannose induces the release of cytopathic factors from Acanthamoeba castellanii. 61
9423832 1998
815
Systemic immune response to Acanthamoeba keratitis in the Chinese hamster. 61
9455740 1997
816
Clinical features and outcome of Acanthamoeba keratitis. 61
9409123 1997
817
Acanthamoeba keratitis and contact lens wear. 61
9371196 1997
818
Outcome of acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine. 61
9331195 1997
819
[Evaluation of effective treatment drugs against Acanthamoeba cyst]. 61
9394554 1997
820
In vitro and in vivo effects of polyhexamethylene biguanide against herpes simplex virus infection. 61
9294689 1997
821
The influence of glaucoma history on graft survival after penetrating keratoplasty. 61
9342604 1997
822
Acanthamoebae bind to rabbit corneal epithelium in vitro. 61
9286276 1997
823
Corneal and conjunctival infections. 61
10170440 1997
824
Treatment of Nocardia asteroides keratitis with polyhexamethylene biguanide. 61
9261318 1997
825
Incidence of acanthamoeba keratitis associated with contact lens wear. 61
9259664 1997
826
Topical anesthetic abuse ring keratitis: report of four cases. 61
9220240 1997
827
Coexistent Acanthamoeba keratitis and herpetic keratitis. 61
9194720 1997
828
Preventing complications in people who wear contact lenses. 61
9250067 1997
829
The role of topical corticosteroids in the management of Acanthamoeba keratitis. 61
9143798 1997
830
Should we be using polyhexamethylene biguanide to treat Acanthamoeba keratitis? 61
9267593 1997
831
Effect of time and washing on the adhesion of Acanthamoeba to extended wear disposable hydrogel contact lenses. 61
9108976 1997
832
Acanthamoeba keratitis associated with contact lenses; report of three cases in Italy. 61
9419845 1997
833
Acanthamoeba keratitis with granulomatous reaction involving the stroma and anterior chamber. 61
9046264 1997
834
[Therapy of advanced amoeba keratitis with keratoplasty à chaud and adjuvant cryotherapy]. 61
9156647 1997
835
Pathogenesis of Acanthamoeba keratitis: carbohydrate-mediated host-parasite interactions. 61
9009294 1997
836
Acanthamoeba keratitis: is water exposure a true risk factor? 61
9001773 1997
837
Acanthamoeba keratitis: masquerading as adenovirus keratitis. 61
9425430 1997
838
Acanthamoeba keratitis. 61
9065937 1997
839
Successful medical treatment of Acanthamoeba keratitis. 61
9700010 1997
840
Contact lenses, disinfectants, and Acanthamoeba keratitis. 61
9097411 1997
841
Rational drug targeting in Acanthamoeba keratitis: implications of host cell-protozoan interaction. 61
9474331 1997
842
In vitro amoebicidal activity of propamidine and pentamidine isethionate against Acanthamoeba species and toxicity to corneal tissues. 61
8985640 1997
843
Free-living, amphizoic and opportunistic amebas. 61
9034567 1997
844
Acanthamoeba keratitis in the south of Sweden. 61
9017049 1996
845
Subgenus systematics of Acanthamoeba: four nuclear 18S rDNA sequence types. 61
8976608 1996
846
Acanthamoeba keratitis: first recorded case from a Palestinian patient with trachoma. 61
8942385 1996
847
Systemic ciclosporin A in high-risk keratoplasties. 61
8871161 1996
848
Acanthamoeba keratitis: risk factors and outcome. 61
8949730 1996
849
The role of macrophages in Acanthamoeba keratitis. 61
8641830 1996
850
Effect of patient wear and extent of protein deposition on adsorption of Acanthamoeba to five types of hydrogel contact lenses. 61
8807646 1996
851
Acanthamoeba keratitis, contact lenses, and the potential health implications of global marketing. 61
8758097 1996
852
[Early clinical diagnosis of acanthamoeba keratitis. A study of 70 eyes]. 61
8766027 1996
853
[Acanthamoeba keratitis]. 61
8692340 1996
854
Treatment of Acanthamoeba keratitis. 61
8711564 1996
855
Acanthamoeba griffini. Molecular characterization of a new corneal pathogen. 61
8595954 1996
856
Confocal microscopy findings of Acanthamoeba keratitis. 61
8623881 1996
857
In vivo confocal microscopy and Acanthamoeba keratitis. 61
8623891 1996
858
Outbreak of keratitis presumed to be caused by Acanthamoeba. 61
8623882 1996
859
Severe microbial keratitis in temperate and tropical Western Australia. 61
8977785 1996
860
Keratoplasty à chaud in severe keratitis. 61
9009359 1996
861
Acanthamoeba keratitis: masquerading as adenoviral keratitis. 61
8977800 1996
862
Risk factors for acanthamoeba keratitis. 61
8563555 1996
863
Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine. 61
8944089 1996
864
Acanthamoeba keratitis: risk factors and outcome. 61
8562539 1995
865
First case of Acanthamoeba keratitis in Malaysia. 61
8594684 1995
866
Decreased corneal sensation as an initial feature of Acanthamoeba keratitis. 61
9097807 1995
867
[A case of Acanthamoeba keratitis after operation for cataract]. 61
7499919 1995
868
Adherence of cysts and trophozoites of Acanthamoeba to unworn rigid gas permeable and soft contact lenses. 61
8565194 1995
869
Risk factors for acanthamoeba keratitis. Population study is required to confirm results. 61
7580456 1995
870
Risk factors for acanthamoeba keratitis. Single use disposable contact lenses should cut risk. 61
7580457 1995
871
Diagnosis and successful medical treatment of Acanthamoeba keratitis. 61
7661744 1995
872
Acanthamoeba keratitis. Contact lens and noncontact lens characteristics. 61
9097775 1995
873
Basic science and applications of in vivo microscopy. 61
10150888 1995
874
Characterization of a plasminogen activator produced by Acanthamoeba castellanii. 61
8577323 1995
875
Cytologic diagnosis of Acanthamoeba keratitis. Report of a case with correlative study with indirect immunofluorescence and scanning electron microscopy. 61
7631564 1995
876
Acanthamoeba keratitis. 61
10707721 1995
877
Risk factors for acanthamoeba keratitis in contact lens users: a case-control study. 61
7787645 1995
878
Chemotherapy for acanthamoeba keratitis. 61
7891501 1995
879
Chemotherapy for acanthamoeba keratitis. 61
7891502 1995
880
Successful immunization against Acanthamoeba keratitis in a pig model. 61
7743802 1995
881
Acanthamoeba keratitis: increasing the index of suspicion. 61
7780895 1995
882
Microbiological quality in Finnish public swimming pools and whirlpools with special reference to free living amoebae: a risk factor for contact lens wearers? 61
7696241 1995
883
Amoebicidal efficiencies of various diamidines against two strains of Acanthamoeba polyphaga. 61
7726493 1995
884
Corneal virulence, cytopathic effect on human keratocytes and genetic characterization of Acanthamoeba. 61
7622330 1995
885
The effect of Acanthamoeba concentration on adherence to four types of unworn soft contact lenses. 61
7712602 1995
886
[A nation-wide survey on the occurrence of amoebic keratitis in Japan]. 61
7887330 1995
887
Chlorhexidine or polyhexamethylene biguanide for acanthamoeba keratitis. 61
7815880 1995
888
Acanthamoeba keratitis. 61
7712613 1995
889
Diagnosis of Acanthamoeba keratitis in vivo with confocal microscopy. 61
7712728 1995
890
Drug therapy in a murine model of Acanthamoeba keratitis. 61
7713244 1995
891
Capnocytophaga keratitis. A clinicopathologic study of three patients, including electron microscopic observations. 61
</